{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T16:43:29Z","timestamp":1794933809025,"version":"4.9.1"},"reference-count":240,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Argentina National Research Council","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Medical Research Council","award":["MR\/X001520\/1"],"award-info":[{"award-number":["MR\/X001520\/1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Muscle"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Double Homeobox 4 (DUX4) is a potent transcription factor encoded by a retrogene mapped in D4Z4 repeated elements on chromosome 4q35. DUX4 has emerged as pivotal in the pathomechanisms of facioscapulohumeral muscular dystrophy (FSHD), a relatively common hereditary muscle wasting condition, although classified as a rare disease. DUX4 contributes to zygote genome activation before its expression is repressed in most somatic tissues through epigenetic mechanisms, including DNA methylation and chromatin modifications. In FSHD, inappropriate activation of <jats:italic>DUX4<\/jats:italic> expression is driven by a complex interplay of genomic and epigenetic alterations. The ectopic presence of DUX4 in skeletal muscle cells activates genes, viral elements and pathways that are typical of very early embryonic development, disturbing cell function and ultimately contributing to muscle weakness and wasting. This review first traces the history of DUX4, from the FSHD genetic linkage studies in the early 1990s, through to identification and characterization of the <jats:italic>DUX4<\/jats:italic> gene in 1999. We then discuss the seminal studies that showed how and why <jats:italic>DUX4<\/jats:italic> is expressed in FSHD and the effects of this ectopic expression in muscle, notably cellular toxicity. Other pathological roles of DUX4, such as participation in cancer and viral infection, are also highlighted. Maintenance of <jats:italic>DUX4<\/jats:italic> in the genome was explained by discovery of the function of DUX4 in zygotic genome activation to institute the totipotent cells of the embryo. Thus, we encompass the gradual transition of <jats:italic>DUX4<\/jats:italic> over the past 25 years from being considered a pseudogene in \u201cjunk DNA\u201d to becoming central to understanding the molecular pathogenesis of FSHD and the primary focus for FSHD therapeutics.<\/jats:p>","DOI":"10.1186\/s13395-025-00388-0","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T07:56:43Z","timestamp":1756108603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["DUX4 at 25: how it emerged from \u201cjunk DNA\u201d to become the cause of facioscapulohumeral muscular dystrophy"],"prefix":"10.1186","volume":"15","author":[{"given":"Alexandra","family":"Belayew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto L.","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Zammit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"388_CR1","doi-asserted-by":"crossref","unstructured":"Deenen JC, Verbeek AL, Verschuuren JJ, van Engelen BG, Voermans NC. Prevalence and incidence rates of 17 neuromuscular disorders: an updated review of the literature. J Neuromuscul Dis. 2025;22143602241313118","DOI":"10.1177\/22143602241313118"},{"issue":"1","key":"388_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1017\/cjn.2015.311","volume":"43","author":"JK Mah","year":"2016","unstructured":"Mah JK, Korngut L, Fiest KM, Dykeman J, Day LJ, Pringsheim T, Jette N. A systematic review and Meta-analysis on the epidemiology of the muscular dystrophies. Can J Neurol Sci. 2016;43(1):163\u201377.","journal-title":"Can J Neurol Sci"},{"issue":"12","key":"388_CR3","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.nmd.2023.10.020","volume":"33","author":"J Kools","year":"2023","unstructured":"Kools J, Deenen JC, Blokhuis AM, Verbeek AL, Voermans NC, van Engelen BG. The Dutch registry for facioscapulohumeral muscular dystrophy: cohort profile and longitudinal patient reported outcomes. Neuromuscul Disord. 2023;33(12):964\u201371.","journal-title":"Neuromuscul Disord"},{"issue":"8","key":"388_CR4","doi-asserted-by":"publisher","first-page":"e13695","DOI":"10.15252\/emmm.202013695","volume":"13","author":"CRS Banerji","year":"2021","unstructured":"Banerji CRS, Zammit PS. Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7. EMBO Mol Med. 2021;13(8):e13695.","journal-title":"EMBO Mol Med"},{"key":"388_CR5","unstructured":"Padberg GWAM. Facioscapulohumeral disease. Doctoral Thesis, Leiden University 1982, (http:\/\/hdl.handle.net\/1887\/25818)."},{"issue":"2","key":"388_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/(SICI)1096-8628(19980501)77:2<155::AID-AJMG9>3.0.CO;2-R","volume":"77","author":"M Zatz","year":"1998","unstructured":"Zatz M, Marie SK, Cerqueira A, Vainzof M, Pavanello RC, Passos-Bueno MR. The facioscapulohumeral muscular dystrophy (FSHD1) gene affects males more severely and more frequently than females. Am J Med Genet. 1998;77(2):155\u201361.","journal-title":"Am J Med Genet"},{"issue":"2","key":"388_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1212\/WNL.43.2.345","volume":"43","author":"R Tawil","year":"1993","unstructured":"Tawil R, Storvick D, Feasby TE, Weiffenbach B, Griggs RC. Extreme variability of expression in monozygotic twins with FSH muscular dystrophy. Neurology. 1993;43(2):345\u20138.","journal-title":"Neurology"},{"issue":"4","key":"388_CR8","doi-asserted-by":"publisher","first-page":"640","DOI":"10.7326\/0003-4819-32-4-640","volume":"32","author":"FH Tyler","year":"1950","unstructured":"Tyler FH, Stephens FE. Studies in disorders of muscle. II clinical manifestations and inheritance of facioscapulohumeral dystrophy in a large family. Ann Intern Med. 1950;32(4):640\u201360.","journal-title":"Ann Intern Med"},{"key":"388_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/2044-5040-4-12","volume":"4","author":"R Tawil","year":"2014","unstructured":"Tawil R, van der Maarel SM, Tapscott SJ. Facioscapulohumeral dystrophy: the path to consensus on pathophysiology. Skelet Muscle. 2014;4:12.","journal-title":"Skelet Muscle"},{"issue":"Pt 11","key":"388_CR10","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1093\/brain\/awt226","volume":"136","author":"G Ricci","year":"2013","unstructured":"Ricci G, Scionti I, Sera F, Govi M, D\u2019Amico R, Frambolli I, Mele F, Filosto M, Vercelli L, Ruggiero L, et al. Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy. Brain. 2013;136(Pt 11):3408\u201317.","journal-title":"Brain"},{"issue":"4","key":"388_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.nmd.2020.03.001","volume":"30","author":"CRS Banerji","year":"2020","unstructured":"Banerji CRS, Cammish P, Evangelista T, Zammit PS, Straub V, Marini-Bettolo C. Facioscapulohumeral muscular dystrophy 1 patients participating in the UK FSHD registry can be subdivided into 4 patterns of self-reported symptoms. Neuromuscul Disord. 2020;30(4):315\u201328.","journal-title":"Neuromuscul Disord"},{"key":"388_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/B978-0-08-045031-5.00013-X","volume":"101","author":"RW Orrell","year":"2011","unstructured":"Orrell RW. Facioscapulohumeral dystrophy and scapuloperoneal syndromes. Handb Clin Neurol. 2011;101:167\u201380.","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"388_CR13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s00415-009-5342-9","volume":"257","author":"K Eger","year":"2010","unstructured":"Eger K, Jordan B, Habermann S, Zierz S. Beevor\u2019s sign in facioscapulohumeral muscular dystrophy: an old sign with new implications. J Neurol. 2010;257(3):436\u20138.","journal-title":"J Neurol"},{"issue":"2","key":"388_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.cct.2011.11.016","volume":"33","author":"JE Hilbert","year":"2012","unstructured":"Hilbert JE, Kissel JT, Luebbe EA, Martens WB, McDermott MP, Sanders DB, Tawil R, Thornton CA, Moxley RT 3. Registry scientific advisory C: if you build a rare disease registry, will they enroll and will they use it? Methods and data from the National registry of myotonic dystrophy (DM) and facioscapulohumeral muscular dystrophy (FSHD). Contemp Clin Trials. 2012;33(2):302\u201311.","journal-title":"Contemp Clin Trials"},{"key":"388_CR15","doi-asserted-by":"crossref","unstructured":"Eichinger K, Heatwole C, Iyadurai S, King W, Baker L, Heininger S, Bartlett A, Dilek N, Martens WB, McDermott M, et al. Facioscapulohumeral muscular dystrophy functional composite outcome measure. Muscle Nerve. 2018. 10.1002:mus.26088.","DOI":"10.1002\/mus.26088"},{"issue":"10","key":"388_CR16","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1212\/WNL.54.10.1927","volume":"54","author":"KJ Felice","year":"2000","unstructured":"Felice KJ, North WA, Moore SA, Mathews KD. FSH dystrophy 4q35 deletion in patients presenting with facial-sparing scapular myopathy. Neurology. 2000;54(10):1927\u201331.","journal-title":"Neurology"},{"issue":"6","key":"388_CR17","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/mus.26474","volume":"59","author":"G Ricci","year":"2019","unstructured":"Ricci G, Cammish P, Siciliano G, Tupler R, Lochmuller H, Evangelista T. Phenotype May predict the clinical course of facioscapolohumeral muscular dystrophy. Muscle Nerve. 2019;59(6):711\u20133.","journal-title":"Muscle Nerve"},{"issue":"4","key":"388_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.nmd.2011.02.002","volume":"21","author":"RB Fitzsimons","year":"2011","unstructured":"Fitzsimons RB. Retinal vascular disease and the pathogenesis of facioscapulohumeral muscular dystrophy. A signalling message from wnt?? Neuromuscul Disord. 2011;21(4):263\u201371.","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"388_CR19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1212\/WNL.0000000000001783","volume":"85","author":"R Tawil","year":"2015","unstructured":"Tawil R, Kissel JT, Heatwole C, Pandya S, Gronseth G, Benatar M, Guideline Development D, Implementation Subcommittee of the American Academy of N, Practice Issues Review Panel of the American Association of N, Electrodiagnostic M. Evidence-based guideline summary: evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy: report of the guideline development, dissemination, and implementation subcommittee of the American academy of neurology and the practice issues review panel of the American association of neuromuscular & electrodiagnostic medicine. Neurology. 2015;85(4):357\u201364.","journal-title":"Neurology"},{"issue":"3","key":"388_CR20","first-page":"159","volume":"29","author":"GP van Dijk","year":"2014","unstructured":"van Dijk GP, van der Kooi E, Behin A, Smeets J, Timmermans J, van der Maarel S, Padberg G, Voermans N, van Engelen B. High prevalence of incomplete right bundle branch block in facioscapulohumeral muscular dystrophy without cardiac symptoms. Funct Neurol. 2014;29(3):159\u201365.","journal-title":"Funct Neurol"},{"key":"388_CR21","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12883-016-0664-6","volume":"16","author":"RJ Goselink","year":"2016","unstructured":"Goselink RJ, Schreuder TH, Mul K, Voermans NC, Pelsma M, de Groot IJ, van Alfen N, Franck B, Theelen T, Lemmers RJ, et al. Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD). BMC Neurol. 2016;16:138.","journal-title":"BMC Neurol"},{"issue":"1","key":"388_CR22","doi-asserted-by":"publisher","first-page":"e007798","DOI":"10.1136\/bmjopen-2015-007798","volume":"6","author":"A Nikolic","year":"2016","unstructured":"Nikolic A, Ricci G, Sera F, Bucci E, Govi M, Mele F, Rossi M, Ruggiero L, Vercelli L, Ravaglia S, et al. Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1\u20133 D4Z4 reduced alleles: experience of the FSHD Italian National registry. BMJ Open. 2016;6(1):e007798.","journal-title":"BMJ Open"},{"issue":"5999","key":"388_CR23","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1126\/science.1189044","volume":"329","author":"RJ Lemmers","year":"2010","unstructured":"Lemmers RJ, van der Vliet PJ, Klooster R, Sacconi S, Camano P, Dauwerse JG, Snider L, Straasheijm KR, van Ommen GJ, Padberg GW, et al. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science. 2010;329(5999):1650\u20133.","journal-title":"Science"},{"issue":"1","key":"388_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0378-1119(99)00267-X","volume":"236","author":"J Gabri\u00ebls","year":"1999","unstructured":"Gabri\u00ebls J, Beckers MC, Ding H, De Vriese A, Plaisance S, van der Maarel SM, Padberg GW, Frants RR, Hewitt JE, Collen D, et al. Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3\u00a0kb element. Gene. 1999;236(1):25\u201332.","journal-title":"Gene"},{"issue":"8","key":"388_CR25","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.nmd.2007.04.002","volume":"17","author":"V Kowaljow","year":"2007","unstructured":"Kowaljow V, Marcowycz A, Ansseau E, Conde CB, Sauvage S, Matteotti C, Arias C, Corona ED, Nunez NG, Leo O, et al. The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscul Disord. 2007;17(8):611\u201323.","journal-title":"Neuromuscul Disord"},{"issue":"46","key":"388_CR26","doi-asserted-by":"publisher","first-page":"18157","DOI":"10.1073\/pnas.0708659104","volume":"104","author":"M Dixit","year":"2007","unstructured":"Dixit M, Ansseau E, Tassin A, Winokur S, Shi R, Qian H, Sauvage S, Matteotti C, van Acker AM, Leo O, et al. DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc Natl Acad Sci U S A. 2007;104(46):18157\u201362.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"388_CR27","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.nmd.2016.09.015","volume":"26","author":"LV Gatica","year":"2016","unstructured":"Gatica LV, Rosa AL. A complex interplay of genetic and epigenetic events leads to abnormal expression of the DUX4 gene in facioscapulohumeral muscular dystrophy. Neuromuscul Disord. 2016;26(12):844\u201352.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"388_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00439-011-1100-z","volume":"131","author":"M Richards","year":"2012","unstructured":"Richards M, Coppee F, Thomas N, Belayew A, Upadhyaya M. Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled? Hum Genet. 2012;131(3):325\u201340.","journal-title":"Hum Genet"},{"issue":"R2","key":"388_CR29","doi-asserted-by":"publisher","first-page":"R153","DOI":"10.1093\/hmg\/ddy162","volume":"27","author":"AE Campbell","year":"2018","unstructured":"Campbell AE, Belleville AE, Resnick R, Shadle SC, Tapscott SJ. Facioscapulohumeral dystrophy: activating an early embryonic transcriptional program in human skeletal muscle. Hum Mol Genet. 2018;27(R2):R153\u201362.","journal-title":"Hum Mol Genet"},{"key":"388_CR30","doi-asserted-by":"crossref","unstructured":"Meryon E. On granular and fatty degeneration of the voluntary muscles. Med Chir Trans 1852, 35:73\u201384.","DOI":"10.1177\/095952875203500108"},{"key":"388_CR31","unstructured":"Cruveilhiers J. M\u00e9moire Sur La paralysie musculaire atrophique. Bulletins de l\u2019Acad\u00e9mie de M\u00e9decine 1852\u20133, 18:490\u2013502, 546\u2013583."},{"key":"388_CR32","unstructured":"Duchenne G-BA. Recherches Sur La paralysie musculaire pseudohypertrophique, Ou paralysie myo-scl\u00e9rosique. Arch G\u00e9n M\u00e9d 1868, 11:5\u201325,179\u2013209, 305\u2013321, 421\u2013443, 552\u2013588."},{"key":"388_CR33","first-page":"53","volume":"98","author":"L Landouzy","year":"1884","unstructured":"Landouzy L, Dejerine J. De La myopathie atrophique progressive (myopathie h\u00e9r\u00e9rlitaire d\u00e9butant, Dans l\u2019enfance, par La face, Sans alt\u00e9ration du syst\u00e8me nerveux). Comptes Rendus Hebdomadaires Des S\u00e9ances De l\u2019Acad\u00e9mie Des Sciences. 1884;98:53\u20135.","journal-title":"Comptes Rendus Hebdomadaires Des S\u00e9ances De l\u2019Acad\u00e9mie Des Sciences"},{"key":"388_CR34","unstructured":"Landouzy L, Dejerine J. De la myopathie atrophique progressive (myopathie sans neuropathie d\u00e9butant d\u2019ordinaire dans l\u2019enfance par la face. In: Revue de m\u00e9decine. vol. 5: Felix Alcan; 1885: 253\u2013366."},{"issue":"12","key":"388_CR35","first-page":"1041","volume":"138","author":"Y Sorrel-Dejerine","year":"1982","unstructured":"Sorrel-Dejerine Y, Fardeau M. Birth and metamorphosis of Landouzy-Dejerine progressive atrophic myopathy. Rev Neurol (Paris). 1982;138(12):1041\u201351.","journal-title":"Rev Neurol (Paris)"},{"key":"388_CR36","first-page":"467","volume":"34","author":"Erb","year":"1884","unstructured":"Erb W. Ueber die \u2018\u2018juvenile form der progressiven muskelatrophie und Ihre beziehungen Zur sogenannten pseudohypertrophie der muskeln. Deutsch Archiv Klin Med. 1884;34:467\u2013519.","journal-title":"Deutsch Archiv Klin Med"},{"key":"388_CR37","doi-asserted-by":"crossref","unstructured":"Walton JN. Dystrophia Muscularis progressiva. In: Progressive Muskeldystrophie Myotonie \u00b7 Myasthenie: Symposium vom 30 November bis 4 Dezember 1965 anl\u00e4\u00dflich der 125 Wiederkehr des Geburtstages von Wilhelm Erb. Edited by Kuhn E. Berlin, Heidelberg: Springer Berlin Heidelberg; 1966: 57\u201376.","DOI":"10.1007\/978-3-642-92920-5_9"},{"key":"388_CR38","doi-asserted-by":"crossref","unstructured":"Erb WH. Dystrophia muscularis progressiva. Klinische und pathologisch-anatomische studien. Dtsch Z Nervenheilkd 1891, 1:13\u201394.","DOI":"10.1007\/BF01669210"},{"key":"388_CR39","unstructured":"Calder A. The remarkable origins of FSHD research in America. https:\/\/www.fshdsociety.org\/2020\/11\/16\/the-remarkable-origins-of-fshd-research-in-america\/ 2020."},{"issue":"6\u20137","key":"388_CR40","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0960-8966(01)00201-2","volume":"11","author":"KM Flanigan","year":"2001","unstructured":"Flanigan KM, Coffeen CM, Sexton L, Stauffer D, Brunner S, Leppert MF. Genetic characterization of a large, historically significant Utah kindred with facioscapulohumeral dystrophy. Neuromuscul Disord. 2001;11(6\u20137):525\u20139.","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"388_CR41","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman EP, Brown RH Jr., Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987;51(6):919\u201328.","journal-title":"Cell"},{"issue":"8","key":"388_CR42","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/jmg.26.8.535","volume":"26","author":"PW Lunt","year":"1989","unstructured":"Lunt PW. A workshop on facioscapulohumeral (Landouzy-Dejerine) disease, manchester, 16 to 17 November 1988. J Med Genet. 1989;26(8):535\u20137.","journal-title":"J Med Genet"},{"issue":"8","key":"388_CR43","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/jmg.26.8.481","volume":"26","author":"M Sarfarazi","year":"1989","unstructured":"Sarfarazi M, Upadhyaya M, Padberg G, Pericak-Vance M, Siddique T, Lucotte G, Lunt P. An exclusion map for facioscapulohumeral (Landouzy-Dejerine) disease. J Med Genet. 1989;26(8):481\u20134.","journal-title":"J Med Genet"},{"issue":"8726","key":"388_CR44","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/0140-6736(90)93005-A","volume":"336","author":"M Upadhyaya","year":"1990","unstructured":"Upadhyaya M, Lunt PW, Sarfarazi M, Broadhead W, Daniels J, Owen M, Harper PS. DNA marker applicable to presymptomatic and prenatal diagnosis of facioscapulohumeral disease. Lancet. 1990;336(8726):1320\u20131.","journal-title":"Lancet"},{"issue":"8716","key":"388_CR45","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/0140-6736(90)92148-B","volume":"336","author":"C Wijmenga","year":"1990","unstructured":"Wijmenga C, Frants RR, Brouwer OF, Moerer P, Weber JL, Padberg GW. Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet. 1990;336(8716):651\u20133.","journal-title":"Lancet"},{"issue":"1","key":"388_CR46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/ng0992-26","volume":"2","author":"C Wijmenga","year":"1992","unstructured":"Wijmenga C, Hewitt JE, Sandkuijl LA, Clark LN, Wright TJ, Dauwerse HG, Gruter AM, Hofker MH, Moerer P, Williamson R, et al. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet. 1992;2(1):26\u201330.","journal-title":"Nat Genet"},{"issue":"8825","key":"388_CR47","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/0140-6736(92)92885-J","volume":"340","author":"C Wijmenga","year":"1992","unstructured":"Wijmenga C, Brouwer OF, Padberg GW, Frants RR. Transmission of de-novo mutation associated with facioscapulohumeral muscular dystrophy. Lancet. 1992;340(8825):985\u20136.","journal-title":"Lancet"},{"issue":"10","key":"388_CR48","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1093\/hmg\/2.10.1673","volume":"2","author":"TJ Wright","year":"1993","unstructured":"Wright TJ, Wijmenga C, Clark LN, Frants RR, Williamson R, Hewitt JE. Fine mapping of the FSHD gene region orientates the rearranged fragment detected by the probe p13E-11. Hum Mol Genet. 1993;2(10):1673\u20138.","journal-title":"Hum Mol Genet"},{"issue":"10","key":"388_CR49","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/hmg\/2.10.1667","volume":"2","author":"C Wijmenga","year":"1993","unstructured":"Wijmenga C, Wright TJ, Baan MJ, Padberg GW, Williamson R, van Ommen GJ, Hewitt JE, Hofker MH, Frants RR. Physical mapping and YAC-cloning connects four genetically distinct 4qter loci (D4S163, D4S139, D4F35S1 and D4F104S1) in the FSHD gene-region. Hum Mol Genet. 1993;2(10):1667\u201372.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"388_CR50","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1093\/hmg\/2.12.2037","volume":"2","author":"JC van Deutekom","year":"1993","unstructured":"van Deutekom JC, Wijmenga C, van Tienhoven EA, Gruter AM, Hewitt JE, Padberg GW, van Ommen GJ, Hofker MH, Frants RR. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2\u00a0kb tandemly repeated unit. Hum Mol Genet. 1993;2(12):2037\u201342.","journal-title":"Hum Mol Genet"},{"key":"388_CR51","doi-asserted-by":"crossref","unstructured":"Lee JH, Goto K, Matsuda C, Arahata K. Characterization of a tandemly repeated 3.3-kb Kpnl unit in the facioscapulohumeral muscular dystrophy (FSHD) gene region on chromosome 4q35. Muscle Nerve Supplement 1995(2):S6\u201313.","DOI":"10.1002\/mus.880181304"},{"issue":"8","key":"388_CR52","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/hmg\/3.8.1287","volume":"3","author":"JE Hewitt","year":"1994","unstructured":"Hewitt JE, Lyle R, Clark LN, Valleley EM, Wright TJ, Wijmenga C, van Deutekom JC, Francis F, Sharpe PT, Hofker M, et al. Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum Mol Genet. 1994;3(8):1287\u201395.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"388_CR53","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF01553323","volume":"2","author":"ST Winokur","year":"1994","unstructured":"Winokur ST, Bengtsson U, Feddersen J, Mathews KD, Weiffenbach B, Bailey H, Markovich RP, Murray JC, Wasmuth JJ, Altherr MR, et al. The DNA rearrangement associated with facioscapulohumeral muscular dystrophy involves a heterochromatin-associated repetitive element: implications for a role of chromatin structure in the pathogenesis of the disease. Chromosome Res. 1994;2(3):225\u201334.","journal-title":"Chromosome Res"},{"issue":"10","key":"388_CR54","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1093\/hmg\/3.10.1801","volume":"3","author":"U Bengtsson","year":"1994","unstructured":"Bengtsson U, Altherr MR, Wasmuth JJ, Winokur ST. High resolution fluorescence in situ hybridization to linearly extended DNA visually maps a tandem repeat associated with facioscapulohumeral muscular dystrophy immediately adjacent to the telomere of 4q. Hum Mol Genet. 1994;3(10):1801\u20135.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"388_CR55","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000472291","volume":"3","author":"G Deidda","year":"1995","unstructured":"Deidda G, Cacurri S, Grisanti P, Vigneti E, Piazzo N, Felicetti L. Physical mapping evidence for a duplicated region on chromosome 10qter showing high homology with the facioscapulohumeral muscular dystrophy locus on chromosome 4qter. Eur J Hum Genetics. 1995;3(3):155\u201367.","journal-title":"Eur J Hum Genetics: EJHG"},{"key":"388_CR56","doi-asserted-by":"crossref","unstructured":"Bakker E, Wijmenga C, Vossen RH, Padberg GW, Hewitt J, van der Wielen M, Rasmussen K, Frants RR. The FSHD-linked locus D4F104S1 (p13E-11) on 4q35 has a homologue on 10qter. Muscle Nerve Supplement 1995(2):S39\u201344.","DOI":"10.1002\/mus.880181309"},{"issue":"3","key":"388_CR57","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ajhg.2010.01.035","volume":"86","author":"RJ Lemmers","year":"2010","unstructured":"Lemmers RJ, van der Vliet PJ, van der Gaag KJ, Zuniga S, Frants RR, de Knijff P, van der Maarel SM. Worldwide population analysis of the 4q and 10q subtelomeres identifies only four discrete interchromosomal sequence transfers in human evolution. Am J Hum Genet. 2010;86(3):364\u201377.","journal-title":"Am J Hum Genet"},{"key":"388_CR58","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2350-8-8","volume":"8","author":"M Rossi","year":"2007","unstructured":"Rossi M, Ricci E, Colantoni L, Galluzzi G, Frusciante R, Tonali PA, Felicetti L. The facioscapulohumeral muscular dystrophy region on 4qter and the homologous locus on 10qter evolved independently under different evolutionary pressure. BMC Med Genet. 2007;8:8.","journal-title":"BMC Med Genet"},{"issue":"5","key":"388_CR59","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1136\/jmg.33.5.361","volume":"33","author":"G Deidda","year":"1996","unstructured":"Deidda G, Cacurri S, Piazzo N, Felicetti L. Direct detection of 4q35 rearrangements implicated in facioscapulohumeral muscular dystrophy (FSHD). J Med Genet. 1996;33(5):361\u20135.","journal-title":"J Med Genet"},{"issue":"11","key":"388_CR60","first-page":"823","volume":"36","author":"SM van der Maarel","year":"1999","unstructured":"van der Maarel SM, Deidda G, Lemmers RJ, Bakker E, van der Wielen MJ, Sandkuijl L, Hewitt JE, Padberg GW, Frants RR. A new dosage test for subtelomeric 4;10 translocations improves conventional diagnosis of facioscapulohumeral muscular dystrophy (FSHD). J Med Genet. 1999;36(11):823\u20138.","journal-title":"J Med Genet"},{"key":"388_CR61","first-page":"366","volume":"23","author":"S Ohno","year":"1972","unstructured":"Ohno S. So much junk DNA in our genome. Brookhaven Symp Biol. 1972;23:366\u201370.","journal-title":"Brookhaven Symp Biol"},{"issue":"4","key":"388_CR62","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.ajhg.2012.02.019","volume":"90","author":"I Scionti","year":"2012","unstructured":"Scionti I, Greco F, Ricci G, Govi M, Arashiro P, Vercelli L, Berardinelli A, Angelini C, Antonini G, Cao M, et al. Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy. Am J Hum Genet. 2012;90(4):628\u201335.","journal-title":"Am J Hum Genet"},{"issue":"5\u20136","key":"388_CR63","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0960-8966(93)90102-P","volume":"3","author":"C Wijmenga","year":"1993","unstructured":"Wijmenga C, Frants RR, Hewitt JE, van Deutekom JC, van Geel M, Wright TJ, Padberg GW, Hofker MH, van Ommen GJ. Molecular genetics of facioscapulohumeral muscular dystrophy. Neuromuscul Disord. 1993;3(5\u20136):487\u201391.","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"388_CR64","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/hmg\/4.5.951","volume":"4","author":"PW Lunt","year":"1995","unstructured":"Lunt PW, Jardine PE, Koch MC, Maynard J, Osborn M, Williams M, Harper PS, Upadhyaya M. Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD). Hum Mol Genet. 1995;4(5):951\u20138.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"388_CR65","first-page":"99","volume":"56","author":"M Zatz","year":"1995","unstructured":"Zatz M, Marie SK, Passos-Bueno MR, Vainzof M, Campiotto S, Cerqueira A, Wijmenga C, Padberg G, Frants R. High proportion of new mutations and possible anticipation in Brazilian facioscapulohumeral muscular dystrophy families. Am J Hum Genet. 1995;56(1):99\u2013105.","journal-title":"Am J Hum Genet"},{"issue":"9","key":"388_CR66","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1136\/jmg.35.9.778","volume":"35","author":"R Tupler","year":"1998","unstructured":"Tupler R, Barbierato L, Memmi M, Sewry CA, De Grandis D, Maraschio P, Tiepolo L, Ferlini A. Identical de Novo mutation at the D4F104S1 locus in monozygotic male twins affected by facioscapulohumeral muscular dystrophy (FSHD) with different clinical expression. J Med Genet. 1998;35(9):778\u201383.","journal-title":"J Med Genet"},{"key":"388_CR67","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1002\/mus.880181311","volume":"2","author":"RC Griggs","year":"1995","unstructured":"Griggs RC, Tawil R, McDermott M, Forrester J, Figlewicz D, Weiffenbach B. Monozygotic twins with facioscapulohumeral dystrophy (FSHD): implications for genotype\/phenotype correlation. FSH-DY group. Muscle Nerve Supplement. 1995;2:S50\u201355.","journal-title":"Muscle Nerve Supplement"},{"issue":"5","key":"388_CR68","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/jmg.33.5.366","volume":"33","author":"R Tupler","year":"1996","unstructured":"Tupler R, Berardinelli A, Barbierato L, Frants R, Hewitt JE, Lanzi G, Maraschio P, Tiepolo L. Monosomy of distal 4q does not cause facioscapulohumeral muscular dystrophy. J Med Genet. 1996;33(5):366\u201370.","journal-title":"J Med Genet"},{"issue":"12","key":"388_CR69","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1093\/hmg\/5.12.1997","volume":"5","author":"JC van Deutekom","year":"1996","unstructured":"van Deutekom JC, Bakker E, Lemmers RJ, van der Wielen MJ, Bik E, Hofker MH, Padberg GW, Frants RR. Evidence for subtelomeric exchange of 3.3\u00a0kb tandemly repeated units between chromosomes 4q35 and 10q26: implications for genetic counselling and etiology of FSHD1. Hum Mol Genet. 1996;5(12):1997\u20132003.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"388_CR70","first-page":"446","volume":"14","author":"JS Thompson","year":"1994","unstructured":"Thompson JS, Johnson LM, Grunstein M. Specific repression of the yeast silent mating locus HMR by an adjacent telomere. Mol Cell Biol. 1994;14(1):446\u201355.","journal-title":"Mol Cell Biol"},{"issue":"6595","key":"388_CR71","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/383092a0","volume":"383","author":"A Hecht","year":"1996","unstructured":"Hecht A, Strahl-Bolsinger S, Grunstein M. Spreading of transcriptional repressor SIR3 from telomeric heterochromatin. Nature. 1996;383(6595):92\u20136.","journal-title":"Nature"},{"issue":"6","key":"388_CR72","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nsmb.2571","volume":"20","author":"G Stadler","year":"2013","unstructured":"Stadler G, Rahimov F, King OD, Chen JC, Robin JD, Wagner KR, Shay JW, Emerson CP Jr., Wright WE. Telomere position effect regulates DUX4 in human facioscapulohumeral muscular dystrophy. Nat Struct Mol Biol. 2013;20(6):671\u20138.","journal-title":"Nat Struct Mol Biol"},{"issue":"2","key":"388_CR73","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/ng999","volume":"32","author":"RJ Lemmers","year":"2002","unstructured":"Lemmers RJ, de Kievit P, Sandkuijl L, Padberg GW, van Ommen GJ, Frants RR, van der Maarel SM. Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere. Nat Genet. 2002;32(2):235\u20136.","journal-title":"Nat Genet"},{"issue":"2","key":"388_CR74","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1006\/geno.2002.6690","volume":"79","author":"M van Geel","year":"2002","unstructured":"van Geel M, Dickson MC, Beck AF, Bolland DJ, Frants RR, van der Maarel SM, de Jong PJ, Hewitt JE. Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin. Genomics. 2002;79(2):210\u20137.","journal-title":"Genomics"},{"issue":"3","key":"388_CR75","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0092-8674(02)00826-7","volume":"110","author":"D Gabellini","year":"2002","unstructured":"Gabellini D, Green MR, Tupler R. Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell. 2002;110(3):339\u201348.","journal-title":"Cell"},{"issue":"4","key":"388_CR76","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/ng1262","volume":"35","author":"PG van Overveld","year":"2003","unstructured":"van Overveld PG, Lemmers RJ, Sandkuijl LA, Enthoven L, Winokur ST, Bakels F, Padberg GW, van Ommen GJ, Frants RR, van der Maarel SM. Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat Genet. 2003;35(4):315\u20137.","journal-title":"Nat Genet"},{"issue":"4","key":"388_CR77","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/ana.20625","volume":"58","author":"PG van Overveld","year":"2005","unstructured":"van Overveld PG, Enthoven L, Ricci E, Rossi M, Felicetti L, Jeanpierre M, Winokur ST, Frants RR, Padberg GW, van der Maarel SM. Variable hypomethylation of D4Z4 in facioscapulohumeral muscular dystrophy. Ann Neurol. 2005;58(4):569\u201376.","journal-title":"Ann Neurol"},{"issue":"10","key":"388_CR78","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/humu.21091","volume":"30","author":"JC de Greef","year":"2009","unstructured":"de Greef JC, Lemmers RJ, van Engelen BG, Sacconi S, Venance SL, Frants RR, Tawil R, van der Maarel SM. Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHD. Hum Mutat. 2009;30(10):1449\u201359.","journal-title":"Hum Mutat"},{"issue":"7","key":"388_CR79","doi-asserted-by":"publisher","first-page":"e1000559","DOI":"10.1371\/journal.pgen.1000559","volume":"5","author":"W Zeng","year":"2009","unstructured":"Zeng W, de Greef JC, Chen YY, Chien R, Kong X, Gregson HC, Winokur ST, Pyle A, Robertson KD, Schmiesing JA, et al. Specific loss of histone H3 lysine 9 trimethylation and HP1gamma\/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD). PLoS Genet. 2009;5(7):e1000559.","journal-title":"PLoS Genet"},{"issue":"4","key":"388_CR80","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.cell.2012.03.035","volume":"149","author":"DS Cabianca","year":"2012","unstructured":"Cabianca DS, Casa V, Bodega B, Xynos A, Ginelli E, Tanaka Y, Gabellini D. A long NcRNA links copy number variation to a polycomb\/trithorax epigenetic switch in FSHD muscular dystrophy. Cell. 2012;149(4):819\u201331.","journal-title":"Cell"},{"issue":"11","key":"388_CR81","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1128\/MCB.00149-14","volume":"34","author":"CL Himeda","year":"2014","unstructured":"Himeda CL, Debarnot C, Homma S, Beermann ML, Miller JB, Jones PL, Jones TI. Myogenic enhancers regulate expression of the facioscapulohumeral muscular Dystrophy-Associated DUX4 gene. Mol Cell Biol. 2014;34(11):1942\u201355.","journal-title":"Mol Cell Biol"},{"issue":"10","key":"388_CR82","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.1093\/nar\/gkad230","volume":"51","author":"E Mocciaro","year":"2023","unstructured":"Mocciaro E, Giambruno R, Micheloni S, Cernilogar FM, Andolfo A, Consonni C, Pannese M, Ferri G, Runfola V, Schotta G, et al. WDR5 is required for DUX4 expression and its pathological effects in FSHD muscular dystrophy. Nucleic Acids Res. 2023;51(10):5144\u201361.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"388_CR83","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/s41588-021-00893-0","volume":"53","author":"EJ Grow","year":"2021","unstructured":"Grow EJ, Weaver BD, Smith CM, Guo J, Stein P, Shadle SC, Hendrickson PG, Johnson NE, Butterfield RJ, Menafra R, et al. p53 convergently activates Dux\/DUX4 in embryonic stem cells and in facioscapulohumeral muscular dystrophy cell models. Nat Genet. 2021;53(8):1207\u201320.","journal-title":"Nat Genet"},{"issue":"1","key":"388_CR84","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13395-024-00361-3","volume":"14","author":"A Fox","year":"2024","unstructured":"Fox A, Oliva J, Vangipurapu R, Sverdrup FM. SIX transcription factors are necessary for the activation of DUX4 expression in facioscapulohumeral muscular dystrophy. Skelet Muscle. 2024;14(1):30.","journal-title":"Skelet Muscle"},{"key":"388_CR85","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13148-015-0072-6","volume":"7","author":"TI Jones","year":"2015","unstructured":"Jones TI, King OD, Himeda CL, Homma S, Chen JC, Beermann ML, Yan C, Emerson CP Jr., Miller JB, Wagner KR, et al. Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy. Clin Epigenetics. 2015;7:37.","journal-title":"Clin Epigenetics"},{"key":"388_CR86","doi-asserted-by":"crossref","unstructured":"Gould T, Jones TI, Jones PL. Precise epigenetic analysis using targeted bisulfite genomic sequencing distinguishes FSHD1, FSHD2, and healthy subjects. Diagnostics (Basel) 2021, 11(8):1469.","DOI":"10.3390\/diagnostics11081469"},{"issue":"11","key":"388_CR87","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1093\/hmg\/7.11.1681","volume":"7","author":"H Ding","year":"1998","unstructured":"Ding H, Beckers MC, Plaisance S, Marynen P, Collen D, Belayew A. Characterization of a double homeodomain protein (DUX1) encoded by a cDNA homologous to 3.3\u00a0kb dispersed repeated elements. Hum Mol Genet. 1998;7(11):1681\u201394.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"388_CR88","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1093\/nar\/gkn055","volume":"36","author":"K Tsumagari","year":"2008","unstructured":"Tsumagari K, Qi L, Jackson K, Shao C, Lacey M, Sowden J, Tawil R, Vedanarayanan V, Ehrlich M. Epigenetics of a tandem DNA repeat: chromatin DNaseI sensitivity and opposite methylation changes in cancers. Nucleic Acids Res. 2008;36(7):2196\u2013207.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"388_CR89","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1093\/nar\/gkaa146","volume":"48","author":"L Ciszewski","year":"2020","unstructured":"Ciszewski L, Lu-Nguyen N, Slater A, Brennan A, Williams HEL, Dickson G, Searle MS, Popplewell L. G-quadruplex ligands mediate downregulation of DUX4 expression. Nucleic Acids Res. 2020;48(8):4179\u201394.","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"388_CR90","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1016\/j.molcel.2024.07.018","volume":"84","author":"G Bai","year":"2024","unstructured":"Bai G, Endres T, Kuhbacher U, Mengoli V, Greer BH, Peacock EM, Newton MD, Stanage T, Dello Stritto MR, Lungu R, et al. HLTF resolves G4s and promotes G4-induced replication fork slowing to maintain genome stability. Mol Cell. 2024;84(16):3044\u201360.","journal-title":"Mol Cell"},{"issue":"22","key":"388_CR91","doi-asserted-by":"publisher","first-page":"9429","DOI":"10.1093\/nar\/15.22.9429","volume":"15","author":"XY Zhang","year":"1987","unstructured":"Zhang XY, Loflin PT, Gehrke CW, Andrews PA, Ehrlich M. Hypermethylation of human DNA sequences in embryonal carcinoma cells and somatic tissues but not in sperm. Nucleic Acids Res. 1987;15(22):9429\u201349.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"388_CR92","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.devcel.2011.11.013","volume":"22","author":"LN Geng","year":"2012","unstructured":"Geng LN, Yao Z, Snider L, Fong AP, Cech JN, Young JM, van der Maarel SM, Ruzzo WL, Gentleman RC, Tawil R, et al. DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. Dev Cell. 2012;22(1):38\u201351.","journal-title":"Dev Cell"},{"issue":"1","key":"388_CR93","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0378-1119(00)00602-8","volume":"264","author":"M Beckers","year":"2001","unstructured":"Beckers M, Gabriels J, van der Maarel S, De Vriese A, Frants RR, Collen D, Belayew A. Active genes in junk DNA? Characterization of DUX genes embedded within 3.3\u00a0kb repeated elements. Gene. 2001;264(1):51\u20137.","journal-title":"Gene"},{"issue":"3","key":"388_CR94","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1006\/geno.1995.1166","volume":"28","author":"R Lyle","year":"1995","unstructured":"Lyle R, Wright TJ, Clark LN, Hewitt JE. The FSHD-associated repeat, D4Z4, is a member of a dispersed family of homeobox-containing repeats, subsets of which are clustered on the short arms of the acrocentric chromosomes. Genomics. 1995;28(3):389\u201397.","journal-title":"Genomics"},{"issue":"10","key":"388_CR95","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1093\/hmg\/5.10.1567","volume":"5","author":"ST Winokur","year":"1996","unstructured":"Winokur ST, Bengtsson U, Vargas JC, Wasmuth JJ, Altherr MR, Weiffenbach B, Jacobsen SJ. The evolutionary distribution and structural organization of the homeobox-containing repeat D4Z4 indicates a functional role for the ancestral copy in the FSHD region. Hum Mol Genet. 1996;5(10):1567\u201375.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"388_CR96","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00018-003-3285-3","volume":"61","author":"R Tupler","year":"2004","unstructured":"Tupler R, Gabellini D. Molecular basis of facioscapulohumeral muscular dystrophy. Cell Mol Life Sci. 2004;61(5):557\u201366.","journal-title":"Cell Mol Life Sci"},{"key":"388_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-2660(07)00001-6","volume":"61","author":"JR Girton","year":"2008","unstructured":"Girton JR, Johansen KM. Chromatin structure and the regulation of gene expression: the lessons of PEV in Drosophila. Adv Genet. 2008;61:1\u201343.","journal-title":"Adv Genet"},{"issue":"24","key":"388_CR98","doi-asserted-by":"publisher","first-page":"13998","DOI":"10.1016\/S0021-9258(18)71632-3","volume":"264","author":"K Li","year":"1989","unstructured":"Li K, Warner CK, Hodge JA, Minoshima S, Kudoh J, Fukuyama R, Maekawa M, Shimizu Y, Shimizu N, Wallace DC. A human muscle adenine nucleotide translocator gene has four exons, is located on chromosome 4, and is differentially expressed. J Biol Chem. 1989;264(24):13998\u20134004.","journal-title":"J Biol Chem"},{"issue":"2","key":"388_CR99","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/BF00219692","volume":"92","author":"C Wijmenga","year":"1993","unstructured":"Wijmenga C, Winokur ST, Padberg GW, Skraastad MI, Altherr MR, Wasmuth JJ, Murray JC, Hofker MH, Frants RR. The human skeletal muscle adenine nucleotide translocator gene maps to chromosome 4q35 in the region of the facioscapulohumeral muscular dystrophy locus. Hum Genet. 1993;92(2):198\u2013203.","journal-title":"Hum Genet"},{"issue":"5","key":"388_CR100","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/hmg\/5.5.581","volume":"5","author":"JC van Deutekom","year":"1996","unstructured":"van Deutekom JC, Lemmers RJ, Grewal PK, van Geel M, Romberg S, Dauwerse HG, Wright TJ, Padberg GW, Hofker MH, Hewitt JE, et al. Identification of the first gene (FRG1) from the FSHD region on human chromosome 4q35. Hum Mol Genet. 1996;5(5):581\u201390.","journal-title":"Hum Mol Genet"},{"issue":"3\u20134","key":"388_CR101","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000015518","volume":"88","author":"M van Geel","year":"2000","unstructured":"van Geel M, van Deutekom JC, van Staalduinen A, Lemmers RJ, Dickson MC, Hofker MH, Padberg GW, Hewitt JE, de Jong PJ, Frants RR. Identification of a novel beta-tubulin subfamily with one member (TUBB4Q) located near the telomere of chromosome region 4q35. Cytogenet Cell Genet. 2000;88(3\u20134):316\u201321.","journal-title":"Cytogenet Cell Genet"},{"issue":"22","key":"388_CR102","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1093\/hmg\/ddg327","volume":"12","author":"ST Winokur","year":"2003","unstructured":"Winokur ST, Chen YW, Masny PS, Martin JH, Ehmsen JT, Tapscott SJ, van der Maarel SM, Hayashi Y, Flanigan KM. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Hum Mol Genet. 2003;12(22):2895\u2013907.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"388_CR103","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.expneurol.2008.07.022","volume":"214","author":"D Bosnakovski","year":"2008","unstructured":"Bosnakovski D, Lamb S, Simsek T, Xu Z, Belayew A, Perlingeiro R, Kyba M. DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation. Exp Neurol. 2008;214(1):87\u201396.","journal-title":"Exp Neurol"},{"issue":"10","key":"388_CR104","doi-asserted-by":"publisher","first-page":"e7482","DOI":"10.1371\/journal.pone.0007482","volume":"4","author":"E Ansseau","year":"2009","unstructured":"Ansseau E, Laoudj-Chenivesse D, Marcowycz A, Tassin A, Vanderplanck C, Sauvage S, Barro M, Mahieu I, Leroy A, Leclercq I, et al. DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation. PLoS ONE. 2009;4(10):e7482.","journal-title":"PLoS ONE"},{"issue":"20","key":"388_CR105","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1242\/jcs.180372","volume":"129","author":"P Knopp","year":"2016","unstructured":"Knopp P, Krom YD, Banerji CR, Panamarova M, Moyle LA, den Hamer B, van der Maarel SM, Zammit PS. DUX4 induces a transcriptome more characteristic of a less-differentiated cell state and inhibits myogenesis. J Cell Sci. 2016;129(20):3816\u201331.","journal-title":"J Cell Sci"},{"issue":"6","key":"388_CR106","doi-asserted-by":"publisher","first-page":"e1003550","DOI":"10.1371\/journal.pgen.1003550","volume":"9","author":"N Caruso","year":"2013","unstructured":"Caruso N, Herberth B, Bartoli M, Puppo F, Dumonceaux J, Zimmermann A, Denadai S, Lebosse M, Roche S, Geng L, et al. Deregulation of the Protocadherin gene FAT1 alters muscle shapes: implications for the pathogenesis of facioscapulohumeral dystrophy. PLoS Genet. 2013;9(6):e1003550.","journal-title":"PLoS Genet"},{"issue":"1\u20133","key":"388_CR107","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0014-5793(03)00110-8","volume":"537","author":"DJ Yip","year":"2003","unstructured":"Yip DJ, Picketts DJ. Increasing D4Z4 repeat copy number compromises C2C12 myoblast differentiation. FEBS Lett. 2003;537(1\u20133):133\u20138.","journal-title":"FEBS Lett"},{"issue":"9","key":"388_CR108","first-page":"709","volume":"15","author":"C Arias","year":"2005","unstructured":"Arias C, Conde CB, Rosa AL. Cellular toxicity of DUX4, a protein encoded at the fascioscapulo- humeral muscular dystrophy locus FSHD- 1A, depends on nuclear localization. Neuromuscul Disord. 2005;15(9):709.","journal-title":"Neuromuscul Disord"},{"issue":"13","key":"388_CR109","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1093\/hmg\/ddl136","volume":"15","author":"M Kawamura-Saito","year":"2006","unstructured":"Kawamura-Saito M, Yamazaki Y, Kaneko K, Kawaguchi N, Kanda H, Mukai H, Gotoh T, Motoi T, Fukayama M, Aburatani H, et al. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum Mol Genet. 2006;15(13):2125\u201337.","journal-title":"Hum Mol Genet"},{"key":"388_CR110","unstructured":"Coppee F, Matteotti C, Ansseau E, Sauvage S, Leclercq I, Leroy A, Marcowycz A, gerbaux D, Figlewicz D, Ding H et al. The DUX gene family and FSHD. In: FSHD Facioscapulohumeral Muscular Dystrophy: Clinical Medicine and Molecular Cell Biology. Edited by Upadhyaya M, Cooper DN: Taylor & Francis LTD; 2004."},{"issue":"2","key":"388_CR111","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1086\/519311","volume":"81","author":"J Clapp","year":"2007","unstructured":"Clapp J, Mitchell LM, Bolland DJ, Fantes J, Corcoran AE, Scotting PJ, Armour JA, Hewitt JE. Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy. Am J Hum Genet. 2007;81(2):264\u201379.","journal-title":"Am J Hum Genet"},{"issue":"13","key":"388_CR112","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1093\/hmg\/ddp180","volume":"18","author":"L Snider","year":"2009","unstructured":"Snider L, Asawachaicharn A, Tyler AE, Geng LN, Petek LM, Maves L, Miller DG, Lemmers RJ, Winokur ST, Tawil R, et al. RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy. Hum Mol Genet. 2009;18(13):2414\u201330.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"388_CR113","first-page":"386","volume":"3","author":"RD Wuebbles","year":"2010","unstructured":"Wuebbles RD, Long SW, Hanel ML, Jones PL. Testing the effects of FSHD candidate gene expression in vertebrate muscle development. Int J Clin Exp Pathol. 2010;3(4):386\u2013400.","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"388_CR114","doi-asserted-by":"publisher","first-page":"e0150938","DOI":"10.1371\/journal.pone.0150938","volume":"11","author":"TI Jones","year":"2016","unstructured":"Jones TI, Parilla M, Jones PL. Transgenic Drosophila for investigating DUX4 and FRG1, two genes associated with facioscapulohumeral muscular dystrophy (FSHD). PLoS ONE. 2016;11(3):e0150938.","journal-title":"PLoS ONE"},{"issue":"5893","key":"388_CR115","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/300611a0","volume":"300","author":"RD Palmiter","year":"1982","unstructured":"Palmiter RD, Brinster RL, Hammer RE, Trumbauer ME, Rosenfeld MG, Birnberg NC, Evans RM. Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature. 1982;300(5893):611\u20135.","journal-title":"Nature"},{"issue":"1","key":"388_CR116","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/ng0198-56","volume":"18","author":"D Garrick","year":"1998","unstructured":"Garrick D, Fiering S, Martin DI, Whitelaw E. Repeat-induced gene Silencing in mammals. Nat Genet. 1998;18(1):56\u20139.","journal-title":"Nat Genet"},{"issue":"2","key":"388_CR117","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/hyb.2010.0094","volume":"30","author":"LN Geng","year":"2011","unstructured":"Geng LN, Tyler AE, Tapscott SJ. Immunodetection of human double homeobox 4. Hybrid (Larchmt). 2011;30(2):125\u201330.","journal-title":"Hybrid (Larchmt)"},{"issue":"1","key":"388_CR118","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1582-4934.2012.01647.x","volume":"17","author":"A Tassin","year":"2013","unstructured":"Tassin A, Laoudj-Chenivesse D, Vanderplanck C, Barro M, Charron S, Ansseau E, Chen YW, Mercier J, Coppee F, Belayew A. DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy? J Cell Mol Med. 2013;17(1):76\u201389.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"388_CR119","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13104-022-06054-8","volume":"15","author":"ML Beermann","year":"2022","unstructured":"Beermann ML, Homma S, Miller JB. Proximity ligation assay to detect DUX4 protein in FSHD1 muscle: a pilot study. BMC Res Notes. 2022;15(1):163.","journal-title":"BMC Res Notes"},{"issue":"1","key":"388_CR120","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13395-022-00310-y","volume":"13","author":"C Claus","year":"2023","unstructured":"Claus C, Slavin M, Ansseau E, Lancelot C, Bah K, Lassche S, Fievet M, Greco A, Tomaiuolo S, Tassin A, et al. The double homeodomain protein DUX4c is associated with regenerating muscle fibers and RNA-binding proteins. Skelet Muscle. 2023;13(1):5.","journal-title":"Skelet Muscle"},{"issue":"2","key":"388_CR121","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/ana.26668","volume":"94","author":"RN Knox","year":"2023","unstructured":"Knox RN, Eidahl JO, Wallace LM, Choudury SG, Rashnonejad A, Daman K, Guggenbiller MJ, Saad NY, Hoover ME, Zhang L, et al. Post-Translational modifications of the DUX4 protein impact toxic function in FSHD cell models. Ann Neurol. 2023;94(2):398\u2013413.","journal-title":"Ann Neurol"},{"issue":"8","key":"388_CR122","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1101\/gr.202432.115","volume":"26","author":"AJ Gruber","year":"2016","unstructured":"Gruber AJ, Schmidt R, Gruber AR, Martin G, Ghosh S, Belmadani M, Keller W, Zavolan M. A comprehensive analysis of 3\u2019 end sequencing data sets reveals novel polyadenylation signals and the repressive role of heterogeneous ribonucleoprotein C on cleavage and polyadenylation. Genome Res. 2016;26(8):1145\u201359.","journal-title":"Genome Res"},{"issue":"8","key":"388_CR123","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1212\/01.wnl.0000251269.31442.d9","volume":"68","author":"RJ Osborne","year":"2007","unstructured":"Osborne RJ, Welle S, Venance SL, Thornton CA, Tawil R. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy. Neurology. 2007;68(8):569\u201377.","journal-title":"Neurology"},{"issue":"1","key":"388_CR124","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbaexp.2006.11.006","volume":"1769","author":"V Alexiadis","year":"2007","unstructured":"Alexiadis V, Ballestas ME, Sanchez C, Winokur S, Vedanarayanan V, Warren M, Ehrlich M. RNAPol-ChIP analysis of transcription from FSHD-linked tandem repeats and satellite DNA. Biochim Biophys Acta. 2007;1769(1):29\u201340.","journal-title":"Biochim Biophys Acta"},{"issue":"22","key":"388_CR125","doi-asserted-by":"publisher","first-page":"12650","DOI":"10.1073\/pnas.96.22.12650","volume":"96","author":"R Tupler","year":"1999","unstructured":"Tupler R, Perini G, Pellegrino MA, Green MR. Profound misregulation of muscle-specific gene expression in facioscapulohumeral muscular dystrophy. Proc Natl Acad Sci U S A. 1999;96(22):12650\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"388_CR126","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1007\/s00018-021-03833-7","volume":"78","author":"TQ Tran","year":"2021","unstructured":"Tran TQ, Kioussi C. Pitx genes in development and disease. Cell Mol Life Sci. 2021;78(11):4921\u201338.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"388_CR127","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.nmd.2008.09.004","volume":"19","author":"P Dmitriev","year":"2009","unstructured":"Dmitriev P, Lipinski M, Vassetzky YS. Pearls in the junk: dissecting the molecular pathogenesis of facioscapulohumeral muscular dystrophy. Neuromuscul Disord. 2009;19(1):17\u201320.","journal-title":"Neuromuscul Disord"},{"issue":"20","key":"388_CR128","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1038\/emboj.2008.201","volume":"27","author":"D Bosnakovski","year":"2008","unstructured":"Bosnakovski D, Xu Z, Gang EJ, Galindo CL, Liu M, Simsek T, Garner HR, Agha-Mohammadi S, Tassin A, Coppee F, et al. An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. Embo J. 2008;27(20):2766\u201379.","journal-title":"Embo J"},{"issue":"4","key":"388_CR129","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S0960-8966(02)00284-5","volume":"13","author":"ST Winokur","year":"2003","unstructured":"Winokur ST, Barrett K, Martin JH, Forrester JR, Simon M, Tawil R, Chung SA, Masny PS, Figlewicz DA. Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress. Neuromuscul Disord. 2003;13(4):322\u201333.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"388_CR130","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s00109-004-0583-7","volume":"83","author":"D Laoudj-Chenivesse","year":"2005","unstructured":"Laoudj-Chenivesse D, Carnac G, Bisbal C, Hugon G, Bouillot S, Desnuelle C, Vassetzky Y, Fernandez A. Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle. J Mol Med (Berl). 2005;83(3):216\u201324.","journal-title":"J Mol Med (Berl)"},{"issue":"16","key":"388_CR131","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1242\/dev.069088","volume":"139","author":"F Relaix","year":"2012","unstructured":"Relaix F, Zammit PS. Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage. Development. 2012;139(16):2845\u201356.","journal-title":"Development"},{"issue":"1","key":"388_CR132","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/s41467-017-01200-4","volume":"8","author":"CRS Banerji","year":"2017","unstructured":"Banerji CRS, Panamarova M, Hebaishi H, White RB, Relaix F, Severini S, Zammit PS. PAX7 target genes are globally repressed in facioscapulohumeral muscular dystrophy skeletal muscle. Nat Commun. 2017;8(1):2152.","journal-title":"Nat Commun"},{"issue":"11","key":"388_CR133","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.1093\/nar\/gkw141","volume":"44","author":"SH Choi","year":"2016","unstructured":"Choi SH, Gearhart MD, Cui Z, Bosnakovski D, Kim M, Schennum N, Kyba M. DUX4 recruits p300\/CBP through its C-terminus and induces global H3K27 acetylation changes. Nucleic Acids Res. 2016;44(11):5161\u201373.","journal-title":"Nucleic Acids Res"},{"issue":"20","key":"388_CR134","first-page":"4419","volume":"25","author":"S Jagannathan","year":"2016","unstructured":"Jagannathan S, Shadle SC, Resnick R, Snider L, Tawil RN, van der Maarel SM, Bradley RK, Tapscott SJ. Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells. Hum Mol Genet. 2016;25(20):4419\u201331.","journal-title":"Hum Mol Genet"},{"key":"388_CR135","doi-asserted-by":"crossref","unstructured":"Lemmers R, van der Vliet PJ, Blatnik A, Balog J, Zidar J, Henderson D, Goselink R, Tapscott SJ, Voermans NC, Tawil R et al. Chromosome 10q-linked FSHD identifies DUX4 as principal disease gene. J Med Genet 2022;59(2):180\u20138.","DOI":"10.1136\/jmedgenet-2020-107041"},{"issue":"18","key":"388_CR136","doi-asserted-by":"publisher","first-page":"eadl1922","DOI":"10.1126\/sciadv.adl1922","volume":"10","author":"Y Ma","year":"2024","unstructured":"Ma Y, Schwager Karpukhina A, Dib C, Gautier C, Hermine O, Allemand E, Vassetzky YS. Exchange of subtelomeric regions between chromosomes 4q and 10q reverts the FSHD genotype and phenotype. Sci Adv. 2024;10(18):eadl1922.","journal-title":"Sci Adv"},{"issue":"12","key":"388_CR137","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ng.2454","volume":"44","author":"RJ Lemmers","year":"2012","unstructured":"Lemmers RJ, Tawil R, Petek LM, Balog J, Block GJ, Santen GW, Amell AM, van der Vliet PJ, Almomani R, Straasheijm KR, et al. Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet. 2012;44(12):1370\u20134.","journal-title":"Nat Genet"},{"issue":"12","key":"388_CR138","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.nmd.2013.08.009","volume":"23","author":"S Mitsuhashi","year":"2013","unstructured":"Mitsuhashi S, Boyden SE, Estrella EA, Jones TI, Rahimov F, Yu TW, Darras BT, Amato AA, Folkerth RD, Jones PL, et al. Exome sequencing identifies a novel SMCHD1 mutation in facioscapulohumeral muscular dystrophy 2. Neuromuscul Disord. 2013;23(12):975\u201380.","journal-title":"Neuromuscul Disord"},{"issue":"21","key":"388_CR139","doi-asserted-by":"publisher","first-page":"7629","DOI":"10.1073\/pnas.0409375102","volume":"102","author":"ME Blewitt","year":"2005","unstructured":"Blewitt ME, Vickaryous NK, Hemley SJ, Ashe A, Bruxner TJ, Preis JI, Arkell R, Whitelaw E. An N-ethyl-N-nitrosourea screen for genes involved in variegation in the mouse. Proc Natl Acad Sci U S A. 2005;102(21):7629\u201334.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"388_CR140","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.ajhg.2013.08.004","volume":"93","author":"S Sacconi","year":"2013","unstructured":"Sacconi S, Lemmers RJ, Balog J, van der Vliet PJ, Lahaut P, van Nieuwenhuizen MP, Straasheijm KR, Debipersad RD, Vos-Versteeg M, Salviati L, et al. The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1. Am J Hum Genet. 2013;93(4):744\u201351.","journal-title":"Am J Hum Genet"},{"key":"388_CR141","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3389\/fneur.2018.01027","volume":"9","author":"R Cascella","year":"2018","unstructured":"Cascella R, Strafella C, Caputo V, Galota RM, Errichiello V, Scutifero M, Petillo R, Marella GL, Arcangeli M, Colantoni L, et al. Digenic inheritance of shortened repeat units of the D4Z4 region and a Loss-of-Function variant in SMCHD1 in a family with FSHD. Front Neurol. 2018;9:1027.","journal-title":"Front Neurol"},{"key":"388_CR142","doi-asserted-by":"crossref","unstructured":"Huang Z, Yu J, Cui W, Johnson BK, Kim K, Pfeifer GP. The chromosomal protein SMCHD1 regulates DNA methylation and the 2c-like state of embryonic stem cells by antagonizing TET proteins. Sci Adv 2021, 7(4):eabb9149.","DOI":"10.1126\/sciadv.abb9149"},{"issue":"16","key":"388_CR143","doi-asserted-by":"publisher","first-page":"9450","DOI":"10.1093\/nar\/gkae600","volume":"52","author":"MM Wong","year":"2024","unstructured":"Wong MM, Hachmer S, Gardner E, Runfola V, Arezza E, Megeney LA, Emerson CP Jr., Gabellini D, Dilworth FJ. SMCHD1 activates the expression of genes required for the expansion of human myoblasts. Nucleic Acids Res. 2024;52(16):9450\u201362.","journal-title":"Nucleic Acids Res"},{"key":"388_CR144","doi-asserted-by":"crossref","unstructured":"Balog J, Thijssen PE, Shadle S, Straasheijm KR, van der Vliet PJ, Krom YD, van den Boogaard ML, de Jong A, RJ FL, Tawil R et al. Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4. Epigenetics 2015, 10(12):1133\u20131142.","DOI":"10.1080\/15592294.2015.1113798"},{"issue":"5","key":"388_CR145","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.ajhg.2016.03.013","volume":"98","author":"ML van den Boogaard","year":"2016","unstructured":"van den Boogaard ML, Lemmers RJ, Balog J, Wohlgemuth M, Auranen M, Mitsuhashi S, van der Vliet PJ, Straasheijm KR, van den Akker RF, Kriek M, et al. Mutations in DNMT3B modify epigenetic repression of the D4Z4 repeat and the penetrance of facioscapulohumeral dystrophy. Am J Hum Genet. 2016;98(5):1020\u20139.","journal-title":"Am J Hum Genet"},{"issue":"23","key":"388_CR146","doi-asserted-by":"publisher","first-page":"e2441","DOI":"10.1212\/WNL.0000000000009617","volume":"94","author":"K Hamanaka","year":"2020","unstructured":"Hamanaka K, Sikrova D, Mitsuhashi S, Masuda H, Sekiguchi Y, Sugiyama A, Shibuya K, Lemmers R, Goossens R, Ogawa M, et al. Homozygous nonsense variant in LRIF1 associated with facioscapulohumeral muscular dystrophy. Neurology. 2020;94(23):e2441\u20137.","journal-title":"Neurology"},{"key":"388_CR147","doi-asserted-by":"publisher","first-page":"1235589","DOI":"10.3389\/fgene.2023.1235589","volume":"14","author":"C Strafella","year":"2023","unstructured":"Strafella C, Caputo V, Bortolani S, Torchia E, Megalizzi D, Trastulli G, Monforte M, Colantoni L, Caltagirone C, Ricci E, et al. Whole exome sequencing highlights rare variants in CTCF, DNMT1, DNMT3A, EZH2 and SUV39H1 as associated with FSHD. Front Genet. 2023;14:1235589.","journal-title":"Front Genet"},{"issue":"7","key":"388_CR148","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1021\/bi047992w","volume":"44","author":"C Ostlund","year":"2005","unstructured":"Ostlund C, Garcia-Carrasquillo RM, Belayew A, Worman HJ. Intracellular trafficking and dynamics of double homeodomain proteins. Biochemistry. 2005;44(7):2378\u201384.","journal-title":"Biochemistry"},{"issue":"3","key":"388_CR149","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/ana.22275","volume":"69","author":"LM Wallace","year":"2010","unstructured":"Wallace LM, Garwick SE, Mei W, Belayew A, Coppee F, Ladner KJ, Guttridge D, Yang J, Harper SQ. DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann Neurol. 2010;69(3):540\u201352.","journal-title":"Ann Neurol"},{"issue":"10","key":"388_CR150","doi-asserted-by":"publisher","first-page":"e75614","DOI":"10.1371\/journal.pone.0075614","volume":"8","author":"ED Corona","year":"2013","unstructured":"Corona ED, Jacquelin D, Gatica L, Rosa AL. Multiple protein domains contribute to nuclear import and cell toxicity of DUX4, a candidate pathogenic protein for facioscapulohumeral muscular dystrophy. PLoS ONE. 2013;8(10):e75614.","journal-title":"PLoS ONE"},{"issue":"21","key":"388_CR151","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1242\/jcs.205427","volume":"130","author":"D Bosnakovski","year":"2017","unstructured":"Bosnakovski D, Toso EA, Hartweck LM, Magli A, Lee HA, Thompson ER, Dandapat A, Perlingeiro RCR, Kyba M. The DUX4 homeodomains mediate Inhibition of myogenesis and are functionally exchangeable with the Pax7 homeodomain. J Cell Sci. 2017;130(21):3685\u201397.","journal-title":"J Cell Sci"},{"key":"388_CR152","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13395-016-0080-z","volume":"6","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Lee JK, Toso EA, Lee JS, Choi SH, Slattery M, Aihara H, Kyba M. DNA-binding sequence specificity of DUX4. Skelet Muscle. 2016;6:8.","journal-title":"Skelet Muscle"},{"issue":"11","key":"388_CR153","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1016\/j.celrep.2018.11.060","volume":"25","author":"JK Lee","year":"2018","unstructured":"Lee JK, Bosnakovski D, Toso EA, Dinh T, Banerjee S, Bohl TE, Shi K, Orellana K, Kyba M, Aihara H. Crystal structure of the double homeodomain of DUX4 in complex with DNA. Cell Rep. 2018;25(11):2955\u201362.e3.","journal-title":"Cell Rep"},{"issue":"4","key":"388_CR154","doi-asserted-by":"publisher","first-page":"bio033977","DOI":"10.1242\/bio.033977","volume":"7","author":"H Mitsuhashi","year":"2018","unstructured":"Mitsuhashi H, Ishimaru S, Homma S, Yu B, Honma Y, Beermann ML, Miller JB. Functional domains of the FSHD-associated DUX4 protein. Biol Open. 2018;7(4):bio033977.","journal-title":"Biol Open"},{"issue":"9","key":"388_CR155","doi-asserted-by":"publisher","first-page":"eaaw7781","DOI":"10.1126\/sciadv.aaw7781","volume":"5","author":"D Bosnakovski","year":"2019","unstructured":"Bosnakovski D, da Silva MT, Sunny ST, Ener ET, Toso EA, Yuan C, Cui Z, Walters MA, Jadhav A, Kyba M. A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression, and cell death. Sci Adv. 2019;5(9):eaaw7781.","journal-title":"Sci Adv"},{"issue":"4","key":"388_CR156","doi-asserted-by":"publisher","first-page":"104137","DOI":"10.1016\/j.isci.2022.104137","volume":"25","author":"S Vuoristo","year":"2022","unstructured":"Vuoristo S, Bhagat S, Hyden-Granskog C, Yoshihara M, Gawriyski L, Jouhilahti EM, Ranga V, Tamirat M, Huhtala M, Kirjanov I, et al. DUX4 is a multifunctional factor priming human embryonic genome activation. iScience. 2022;25(4):104137.","journal-title":"iScience"},{"key":"388_CR157","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/1471-2148-10-364","volume":"10","author":"A Leidenroth","year":"2010","unstructured":"Leidenroth A, Hewitt JE. A family history of DUX4: phylogenetic analysis of DUXA, B, C and duxbl reveals the ancestral DUX gene. BMC Evol Biol. 2010;10:364.","journal-title":"BMC Evol Biol"},{"issue":"20","key":"388_CR158","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1002\/1873-3468.14416","volume":"596","author":"J Quintero","year":"2022","unstructured":"Quintero J, Saad NY, Pagnoni SM, Jacquelin DK, Gatica LV, Harper SQ, Rosa AL. The DUX4 protein is a co-repressor of the progesterone and glucocorticoid nuclear receptors. FEBS Lett. 2022;596(20):2644\u201358.","journal-title":"FEBS Lett"},{"issue":"1","key":"388_CR159","doi-asserted-by":"publisher","first-page":"e0146893","DOI":"10.1371\/journal.pone.0146893","volume":"11","author":"E Ansseau","year":"2016","unstructured":"Ansseau E, Eidahl JO, Lancelot C, Tassin A, Matteotti C, Yip C, Liu J, Leroy B, Hubeau C, Gerbaux C, et al. Homologous transcription factors DUX4 and DUX4c associate with cytoplasmic proteins during muscle differentiation. PLoS ONE. 2016;11(1):e0146893.","journal-title":"PLoS ONE"},{"issue":"12","key":"388_CR160","doi-asserted-by":"publisher","first-page":"eaaw7099","DOI":"10.1126\/sciadv.aaw7099","volume":"5","author":"AM DeSimone","year":"2019","unstructured":"DeSimone AM, Leszyk J, Wagner K, Emerson CP Jr. Identification of the hyaluronic acid pathway as a therapeutic target for facioscapulohumeral muscular dystrophy. Sci Adv. 2019;5(12):eaaw7099.","journal-title":"Sci Adv"},{"issue":"20","key":"388_CR161","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.1093\/hmg\/ddv315","volume":"24","author":"AM Rickard","year":"2015","unstructured":"Rickard AM, Petek LM, Miller DG. Endogenous DUX4 expression in FSHD myotubes is sufficient to cause cell death and disrupts RNA splicing and cell migration pathways. Hum Mol Genet. 2015;24(20):5901\u201314.","journal-title":"Hum Mol Genet"},{"key":"388_CR162","doi-asserted-by":"crossref","unstructured":"Jagannathan S, Ogata Y, Gafken PR, Tapscott SJ, Bradley RK. Quantitative proteomics reveals key roles for post-transcriptional gene regulation in the molecular pathology of facioscapulohumeral muscular dystrophy. eLife 2019, 8:e41740.","DOI":"10.7554\/eLife.41740"},{"key":"388_CR163","doi-asserted-by":"publisher","first-page":"e04996","DOI":"10.7554\/eLife.04996","volume":"4","author":"Q Feng","year":"2015","unstructured":"Feng Q, Snider L, Jagannathan S, Tawil R, van der Maarel SM, Tapscott SJ, Bradley RK. A feedback loop between nonsense-mediated decay and the retrogene DUX4 in facioscapulohumeral muscular dystrophy. eLife. 2015;4:e04996.","journal-title":"eLife"},{"issue":"102","key":"388_CR164","doi-asserted-by":"publisher","first-page":"20140797","DOI":"10.1098\/rsif.2014.0797","volume":"12","author":"CR Banerji","year":"2015","unstructured":"Banerji CR, Knopp P, Moyle LA, Severini S, Orrell RW, Teschendorff AE, Zammit PS. \u03b2-Catenin is central to DUX4-driven network rewiring in facioscapulohumeral muscular dystrophy. J R Soc Interface. 2015;12(102):20140797.","journal-title":"J R Soc Interface"},{"key":"388_CR165","doi-asserted-by":"publisher","first-page":"802573","DOI":"10.3389\/fcell.2022.802573","volume":"10","author":"M Ganassi","year":"2022","unstructured":"Ganassi M, Figeac N, Reynaud M, Ortuste Quiroga HP, Zammit PS. Antagonism between DUX4 and DUX4c highlights a pathomechanism operating through beta-Catenin in facioscapulohumeral muscular dystrophy. Front Cell Dev Biology. 2022;10:802573.","journal-title":"Front Cell Dev Biology"},{"key":"388_CR166","doi-asserted-by":"crossref","unstructured":"Ansseau E, Nachtegael C, Pieters K, Vanderplanck C, Geens M, Sermon K, Wilton SD, Coppee F, Lagneaux L et al. The Role of D4Z4-Encoded Proteins in the Osteogenic Differentiation of Mesenchymal Stromal Cells Isolated from Bone Marrow. Stem Cells Dev 2015, 24(22):2674\u201386.","DOI":"10.1089\/scd.2014.0575"},{"issue":"11","key":"388_CR167","doi-asserted-by":"publisher","first-page":"e1003947","DOI":"10.1371\/journal.pgen.1003947","volume":"9","author":"JM Young","year":"2013","unstructured":"Young JM, Whiddon JL, Yao Z, Kasinathan B, Snider L, Geng LN, Balog J, Tawil R, van der Maarel SM, Tapscott SJ. DUX4 binding to retroelements creates promoters that are active in FSHD muscle and testis. PLoS Genet. 2013;9(11):e1003947.","journal-title":"PLoS Genet"},{"issue":"20","key":"388_CR168","doi-asserted-by":"publisher","first-page":"5342","DOI":"10.1093\/hmg\/ddu251","volume":"23","author":"Z Yao","year":"2014","unstructured":"Yao Z, Snider L, Balog J, Lemmers RJ, Van Der Maarel SM, Tawil R, Tapscott SJ. DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle. Hum Mol Genet. 2014;23(20):5342\u201352.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"388_CR169","doi-asserted-by":"publisher","first-page":"e64691","DOI":"10.1371\/journal.pone.0064691","volume":"8","author":"V Sharma","year":"2013","unstructured":"Sharma V, Harafuji N, Belayew A, Chen YW. DUX4 differentially regulates transcriptomes of human rhabdomyosarcoma and mouse C2C12 cells. PLoS ONE. 2013;8(5):e64691.","journal-title":"PLoS ONE"},{"issue":"10","key":"388_CR170","doi-asserted-by":"publisher","first-page":"e1001181","DOI":"10.1371\/journal.pgen.1001181","volume":"6","author":"L Snider","year":"2010","unstructured":"Snider L, Geng LN, Lemmers RJ, Kyba M, Ware CB, Nelson AM, Tawil R, Filippova GN, van der Maarel SM, Tapscott SJ, et al. Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. PLoS Genet. 2010;6(10):e1001181.","journal-title":"PLoS Genet"},{"issue":"40","key":"388_CR171","doi-asserted-by":"publisher","first-page":"16234","DOI":"10.1073\/pnas.1209508109","volume":"109","author":"F Rahimov","year":"2012","unstructured":"Rahimov F, King OD, Leung DG, Bibat GM, Emerson CP Jr., Kunkel LM, Wagner KR. Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers. Proc Natl Acad Sci U S A. 2012;109(40):16234\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"388_CR172","doi-asserted-by":"publisher","first-page":"e38779","DOI":"10.1371\/journal.pone.0038779","volume":"7","author":"G Tasca","year":"2012","unstructured":"Tasca G, Pescatori M, Monforte M, Mirabella M, Iannaccone E, Frusciante R, Cubeddu T, Laschena F, Ottaviani P, Ricci E. Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles. PLoS ONE. 2012;7(6):e38779.","journal-title":"PLoS ONE"},{"issue":"20","key":"388_CR173","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.1093\/hmg\/ddt272","volume":"22","author":"N Broucqsault","year":"2013","unstructured":"Broucqsault N, Morere J, Gaillard MC, Dumonceaux J, Torrents J, Salort-Campana E, Maues De Paula A, Bartoli M, Fernandez C, Chesnais AL, et al. Dysregulation of 4q35- and muscle-specific genes in fetuses with a short D4Z4 array linked to facio-scapulo-humeral dystrophy. Hum Mol Genet. 2013;22(20):4206\u201314.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"388_CR174","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/hmg\/ddt409","volume":"23","author":"M Ferreboeuf","year":"2014","unstructured":"Ferreboeuf M, Mariot V, Bessieres B, Vasiljevic A, Attie-Bitach T, Collardeau S, Morere J, Roche S, Magdinier F, Robin-Ducellier J, et al. DUX4 and DUX4 downstream target genes are expressed in fetal FSHD muscles. Hum Mol Genet. 2014;23(1):171\u201381.","journal-title":"Hum Mol Genet"},{"issue":"13","key":"388_CR175","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1093\/hmg\/ddz043","volume":"28","author":"CRS Banerji","year":"2019","unstructured":"Banerji CRS, Zammit PS. PAX7 target gene repression is a superior FSHD biomarker than DUX4 target gene activation, associating with pathological severity and identifying FSHD at the single-cell level. Hum Mol Genet. 2019;28(13):2224\u201336.","journal-title":"Hum Mol Genet"},{"issue":"13","key":"388_CR176","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1093\/hmg\/ddaa079","volume":"29","author":"CRS Banerji","year":"2020","unstructured":"Banerji CRS. PAX7 target gene repression associates with FSHD progression and pathology over 1 year. Hum Mol Genet. 2020;29(13):2124\u201333.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"388_CR177","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1093\/hmg\/ddaa031","volume":"29","author":"CJ Wong","year":"2020","unstructured":"Wong CJ, Wang LH, Friedman SD, Shaw D, Campbell AE, Budech CB, Lewis LM, Lemmers R, Statland JM, van der Maarel SM, et al. Longitudinal measures of RNA expression and disease activity in FSHD muscle biopsies. Hum Mol Genet. 2020;29(6):1030\u201343.","journal-title":"Hum Mol Genet"},{"issue":"10","key":"388_CR178","doi-asserted-by":"publisher","first-page":"e26820","DOI":"10.1371\/journal.pone.0026820","volume":"6","author":"C Vanderplanck","year":"2011","unstructured":"Vanderplanck C, Ansseau E, Charron S, Stricwant N, Tassin A, Laoudj-Chenivesse D, Wilton SD, Coppee F, Belayew A. The FSHD atrophic myotube phenotype is caused by DUX4 expression. PLoS ONE. 2011;6(10):e26820.","journal-title":"PLoS ONE"},{"issue":"10","key":"388_CR179","first-page":"1211","volume":"10","author":"D Bosnakovski","year":"2017","unstructured":"Bosnakovski D, Gearhart MD, Toso EA, Recht OO, Cucak A, Jain AK, Barton MC, Kyba M. p53-independent DUX4 pathology in cell and animal models of facioscapulohumeral muscular dystrophy. Dis Models Mech. 2017;10(10):1211\u20136.","journal-title":"Dis Models Mech"},{"issue":"3","key":"388_CR180","doi-asserted-by":"publisher","first-page":"e1006658","DOI":"10.1371\/journal.pgen.1006658","volume":"13","author":"SC Shadle","year":"2017","unstructured":"Shadle SC, Zhong JW, Campbell AE, Conerly ML, Jagannathan S, Wong CJ, Morello TD, van der Maarel SM, Tapscott SJ. DUX4-induced DsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy. PLoS Genet. 2017;13(3):e1006658.","journal-title":"PLoS Genet"},{"key":"388_CR181","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.freeradbiomed.2016.08.007","volume":"99","author":"P Dmitriev","year":"2016","unstructured":"Dmitriev P, Bou Saada Y, Dib C, Ansseau E, Barat A, Hamade A, Dessen P, Robert T, Lazar V, Louzada RA, et al. DUX4-induced constitutive DNA damage and oxidative stress contribute to aberrant differentiation of myoblasts from FSHD patients. Free Radic Biol Med. 2016;99:244\u201358.","journal-title":"Free Radic Biol Med"},{"issue":"23","key":"388_CR182","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/hmg\/ddz242","volume":"28","author":"SC Shadle","year":"2019","unstructured":"Shadle SC, Bennett SR, Wong CJ, Karreman NA, Campbell AE, van der Maarel SM, Bass BL, Tapscott SJ. DUX4-induced bidirectional HSATII satellite repeat transcripts form intranuclear double-stranded RNA foci in human cell models of FSHD. Hum Mol Genet. 2019;28(23):3997\u20134011.","journal-title":"Hum Mol Genet"},{"key":"388_CR183","doi-asserted-by":"crossref","unstructured":"Arends T, Tsuchida H, Adeyemi RO, Tapscott SJ. DUX4-induced HSATII transcription causes KDM2A\/B-PRC1 nuclear foci and impairs DNA damage response. J Cell Biol 2024, 223(5):e202303141.","DOI":"10.1083\/jcb.202303141"},{"issue":"23","key":"388_CR184","doi-asserted-by":"publisher","first-page":"4024","DOI":"10.1093\/hmg\/ddy293","volume":"27","author":"M Sasaki-Honda","year":"2018","unstructured":"Sasaki-Honda M, Jonouchi T, Arai M, Hotta A, Mitsuhashi S, Nishino I, Matsuda R, Sakurai H. A patient-derived iPSC model revealed oxidative stress increases facioscapulohumeral muscular dystrophy-causative DUX4. Hum Mol Genet. 2018;27(23):4024\u201335.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"388_CR185","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.freeradbiomed.2012.06.041","volume":"53","author":"A Turki","year":"2012","unstructured":"Turki A, Hayot M, Carnac G, Pillard F, Passerieux E, Bommart S, Raynaud de Mauverger E, Hugon G, Pincemail J, Pietri S, et al. Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction. Free Radic Biol Med. 2012;53(5):1068\u201379.","journal-title":"Free Radic Biol Med"},{"key":"388_CR186","doi-asserted-by":"publisher","first-page":"102251","DOI":"10.1016\/j.redox.2022.102251","volume":"51","author":"P Heher","year":"2022","unstructured":"Heher P, Ganassi M, Weidinger A, Engquist EN, Pruller J, Nguyen TH, Tassin A, Decleves AE, Mamchaoui K, Banerji CRS, et al. Interplay between mitochondrial reactive oxygen species, oxidative stress and hypoxic adaptation in facioscapulohumeral muscular dystrophy: metabolic stress as potential therapeutic target. Redox Biol. 2022;51:102251.","journal-title":"Redox Biol"},{"key":"388_CR187","doi-asserted-by":"publisher","first-page":"102450","DOI":"10.1016\/j.redox.2022.102450","volume":"56","author":"S Arbogast","year":"2022","unstructured":"Arbogast S, Kotzur H, Frank C, Compagnone N, Sutra T, Pillard F, Pietri S, Hmada N, Moussa DMA, Bride J, et al. ANT1 overexpression models: some similarities with facioscapulohumeral muscular dystrophy. Redox Biol. 2022;56:102450.","journal-title":"Redox Biol"},{"key":"388_CR188","doi-asserted-by":"publisher","first-page":"102008","DOI":"10.1016\/j.redox.2021.102008","volume":"43","author":"A Karpukhina","year":"2021","unstructured":"Karpukhina A, Galkin I, Ma Y, Dib C, Zinovkin R, Pletjushkina O, Chernyak B, Popova E, Vassetzky Y. Analysis of genes regulated by DUX4 via oxidative stress reveals potential therapeutic targets for treatment of facioscapulohumeral dystrophy. Redox Biol. 2021;43:102008.","journal-title":"Redox Biol"},{"issue":"1\u20132","key":"388_CR189","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1582-4934.2008.00368.x","volume":"14","author":"M Barro","year":"2010","unstructured":"Barro M, Carnac G, Flavier S, Mercier J, Vassetzky Y, Laoudj-Chenivesse D. Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects. J Cell Mol Med. 2010;14(1\u20132):275\u201389.","journal-title":"J Cell Mol Med"},{"issue":"8","key":"388_CR190","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1093\/hmg\/ddy405","volume":"28","author":"CRS Banerji","year":"2019","unstructured":"Banerji CRS, Panamarova M, Pruller J, Figeac N, Hebaishi H, Fidanis E, Saxena A, Contet J, Sacconi S, Severini S, et al. Dynamic transcriptomic analysis reveals suppression of PGC1alpha\/ERRalpha drives perturbed myogenesis in facioscapulohumeral muscular dystrophy. Hum Mol Genet. 2019;28(8):1244\u201359.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"388_CR191","doi-asserted-by":"publisher","first-page":"16957","DOI":"10.1038\/s41598-018-35150-8","volume":"8","author":"D Bosnakovski","year":"2018","unstructured":"Bosnakovski D, Gearhart MD, Toso EA, Ener ET, Choi SH, Kyba M. Low level DUX4 expression disrupts myogenesis through deregulation of myogenic gene expression. Sci Rep. 2018;8(1):16957.","journal-title":"Sci Rep"},{"key":"388_CR192","doi-asserted-by":"crossref","unstructured":"Lim KRQ, Nguyen Q, Yokota T. DUX4 signalling in the pathogenesis of facioscapulohumeral muscular dystrophy. Int J Mol Sci. 2020;21(3):729.","DOI":"10.3390\/ijms21030729"},{"key":"388_CR193","doi-asserted-by":"crossref","unstructured":"Mocciaro E, Runfola V, Ghezzi P, Pannese M, Gabellini D. DUX4 role in normal physiology and in FSHD muscular dystrophy. Cells. 2021;10(12):3322.","DOI":"10.3390\/cells10123322"},{"issue":"5","key":"388_CR194","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00412-012-0380-y","volume":"121","author":"A Leidenroth","year":"2012","unstructured":"Leidenroth A, Clapp L, Mitchell LM, Coneyworth D, Dearden FL, Iannuzzi L, Hewitt JE. Evolution of DUX gene macrosatellites in placental mammals. Chromosoma. 2012;121(5):489\u201397.","journal-title":"Chromosoma"},{"issue":"10","key":"388_CR195","doi-asserted-by":"publisher","first-page":"dmm046904","DOI":"10.1242\/dmm.046904","volume":"13","author":"AM DeSimone","year":"2020","unstructured":"DeSimone AM, Cohen J, Lek M, Lek A. Cellular and animal models for facioscapulohumeral muscular dystrophy. Dis Models Mech. 2020;13(10):dmm046904.","journal-title":"Dis Models Mech"},{"issue":"4","key":"388_CR196","doi-asserted-by":"publisher","first-page":"e1003415","DOI":"10.1371\/journal.pgen.1003415","volume":"9","author":"YD Krom","year":"2013","unstructured":"Krom YD, Thijssen PE, Young JM, den Hamer B, Balog J, Yao Z, Maves L, Snider L, Knopp P, Zammit PS, et al. Intrinsic epigenetic regulation of the D4Z4 macrosatellite repeat in a Transgenic mouse model for FSHD. PLoS Genet. 2013;9(4):e1003415.","journal-title":"PLoS Genet"},{"issue":"3","key":"388_CR197","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/hmg\/dds467","volume":"22","author":"H Mitsuhashi","year":"2013","unstructured":"Mitsuhashi H, Mitsuhashi S, Lynn-Jones T, Kawahara G, Kunkel LM. Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy. Hum Mol Genet. 2013;22(3):568\u201377.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"388_CR198","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1093\/hmg\/ddy348","volume":"28","author":"A Pakula","year":"2019","unstructured":"Pakula A, Lek A, Widrick J, Mitsuhashi H, Bugda Gwilt KM, Gupta VA, Rahimov F, Criscione J, Zhang Y, Gibbs D, et al. Transgenic zebrafish model of DUX4 misexpression reveals a developmental role in FSHD pathogenesis. Hum Mol Genet. 2019;28(2):320\u201331.","journal-title":"Hum Mol Genet"},{"issue":"5\u20136","key":"388_CR199","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1101\/gad.349172.121","volume":"36","author":"SQ Xie","year":"2022","unstructured":"Xie SQ, Leeke BJ, Whilding C, Wagner RT, Garcia-Llagostera F, Low Y, Chammas P, Cheung NT, Dormann D, McManus MT, et al. Nucleolar-based dux repression is essential for embryonic two-cell stage exit. Genes Dev. 2022;36(5\u20136):331\u201347.","journal-title":"Genes Dev"},{"issue":"5","key":"388_CR200","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.celrep.2014.07.056","volume":"8","author":"A Dandapat","year":"2014","unstructured":"Dandapat A, Bosnakovski D, Hartweck LM, Arpke RW, Baltgalvis KA, Vang D, Baik J, Darabi R, Perlingeiro RC, Hamra FK, et al. Dominant lethal pathologies in male mice engineered to contain an X-linked DUX4 transgene. Cell Rep. 2014;8(5):1484\u201396.","journal-title":"Cell Rep"},{"issue":"3","key":"388_CR201","doi-asserted-by":"publisher","first-page":"e0151467","DOI":"10.1371\/journal.pone.0151467","volume":"11","author":"A Dandapat","year":"2016","unstructured":"Dandapat A, Perrin BJ, Cabelka C, Razzoli M, Ervasti JM, Bartolomucci A, Lowe DA, Kyba M. High frequency hearing loss and hyperactivity in DUX4 Transgenic mice. PLoS ONE. 2016;11(3):e0151467.","journal-title":"PLoS ONE"},{"issue":"1","key":"388_CR202","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41467-017-00730-1","volume":"8","author":"D Bosnakovski","year":"2017","unstructured":"Bosnakovski D, Chan SSK, Recht OO, Hartweck LM, Gustafson CJ, Athman LL, Lowe DA, Kyba M. Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model. Nat Commun. 2017;8(1):550.","journal-title":"Nat Commun"},{"issue":"5","key":"388_CR203","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1172\/JCI133303","volume":"130","author":"D Bosnakovski","year":"2020","unstructured":"Bosnakovski D, Shams AS, Yuan C, da Silva MT, Ener ET, Baumann CW, Lindsay AJ, Verma M, Asakura A, Lowe DA, et al. Transcriptional and cytopathological hallmarks of FSHD in chronic DUX4-expressing mice. J Clin Invest. 2020;130(5):2465\u201377.","journal-title":"J Clin Invest"},{"issue":"22","key":"388_CR204","doi-asserted-by":"publisher","first-page":"e123538","DOI":"10.1172\/jci.insight.123538","volume":"3","author":"CR Giesige","year":"2018","unstructured":"Giesige CR, Wallace LM, Heller KN, Eidahl JO, Saad NY, Fowler AM, Pyne NK, Al-Kharsan M, Rashnonejad A, Chermahini GA, et al. AAV-mediated follistatin gene therapy improves functional outcomes in the TIC-DUX4 mouse model of FSHD. JCI Insight. 2018;3(22):e123538.","journal-title":"JCI Insight"},{"issue":"2","key":"388_CR205","doi-asserted-by":"publisher","first-page":"e0192657","DOI":"10.1371\/journal.pone.0192657","volume":"13","author":"T Jones","year":"2018","unstructured":"Jones T, Jones PL. A cre-inducible DUX4 Transgenic mouse model for investigating facioscapulohumeral muscular dystrophy. PLoS ONE. 2018;13(2):e0192657.","journal-title":"PLoS ONE"},{"issue":"1","key":"388_CR206","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/2044-5040-2-8","volume":"2","author":"JJ McCarthy","year":"2012","unstructured":"McCarthy JJ, Srikuea R, Kirby TJ, Peterson CA, Esser KA. Inducible Cre Transgenic mouse strain for skeletal muscle-specific gene targeting. Skelet Muscle. 2012;2(1):8.","journal-title":"Skelet Muscle"},{"issue":"1","key":"388_CR207","doi-asserted-by":"publisher","first-page":"11301","DOI":"10.1038\/s41598-020-68135-7","volume":"10","author":"A Derenne","year":"2020","unstructured":"Derenne A, Tassin A, Nguyen TH, De Roeck E, Jenart V, Ansseau E, Belayew A, Coppee F, Decleves AE, Legrand A. Induction of a local muscular dystrophy using electroporation in vivo: an easy tool for screening therapeutics. Sci Rep. 2020;10(1):11301.","journal-title":"Sci Rep"},{"key":"388_CR208","unstructured":"Jones PA. https:\/\/myfshd.org\/wp-content\/uploads\/2021\/04\/myfshd-animal-model-pig1.pdf. 2021."},{"issue":"11","key":"388_CR209","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1093\/hmg\/ddad021","volume":"32","author":"Y Nip","year":"2023","unstructured":"Nip Y, Bennett SR, Smith AA, Jones TI, Jones PL, Tapscott SJ. Human DUX4 and Porcine DUXC activate similar early embryonic programs in pig muscle cells: implications for preclinical models of FSHD. Hum Mol Genet. 2023;32(11):1864\u201374.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"388_CR210","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1093\/hmg\/ddu028","volume":"23","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, King OD, Rahimov F, Jones TI, Ward CW, Kerr JP, Liu N, Emerson CP Jr., Kunkel LM, Partridge TA, et al. Human skeletal muscle xenograft as a new preclinical model for muscle disorders. Hum Mol Genet. 2014;23(12):3180\u20138.","journal-title":"Hum Mol Genet"},{"key":"388_CR211","doi-asserted-by":"publisher","first-page":"113011","DOI":"10.1016\/j.expneurol.2019.113011","volume":"320","author":"AL Mueller","year":"2019","unstructured":"Mueller AL, O\u2019Neill A, Jones TI, Llach A, Rojas LA, Sakellariou P, Stadler G, Wright WE, Eyerman D, Jones PL, et al. Muscle xenografts reproduce key molecular features of facioscapulohumeral muscular dystrophy. Exp Neurol. 2019;320:113011.","journal-title":"Exp Neurol"},{"issue":"6","key":"388_CR212","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/ng.3844","volume":"49","author":"PG Hendrickson","year":"2017","unstructured":"Hendrickson PG, Dorais JA, Grow EJ, Whiddon JL, Lim JW, Wike CL, Weaver BD, Pflueger C, Emery BR, Wilcox AL, et al. Conserved roles of mouse DUX and human DUX4 in activating cleavage-stage genes and MERVL\/HERVL retrotransposons. Nat Genet. 2017;49(6):925\u201334.","journal-title":"Nat Genet"},{"issue":"6","key":"388_CR213","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/ng.3846","volume":"49","author":"JL Whiddon","year":"2017","unstructured":"Whiddon JL, Langford AT, Wong CJ, Zhong JW, Tapscott SJ. Conservation and innovation in the DUX4-family gene network. Nat Genet. 2017;49(6):935\u201340.","journal-title":"Nat Genet"},{"issue":"6","key":"388_CR214","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/ng.3858","volume":"49","author":"A De Iaco","year":"2017","unstructured":"De Iaco A, Planet E, Coluccio A, Verp S, Duc J, Trono D. DUX-family transcription factors regulate zygotic genome activation in placental mammals. Nat Genet. 2017;49(6):941\u20135.","journal-title":"Nat Genet"},{"issue":"7","key":"388_CR215","doi-asserted-by":"publisher","first-page":"e0160022","DOI":"10.1371\/journal.pone.0160022","volume":"11","author":"S Das","year":"2016","unstructured":"Das S, Chadwick BP. Influence of repressive histone and DNA methylation upon D4Z4 transcription in Non-Myogenic cells. PLoS ONE. 2016;11(7):e0160022.","journal-title":"PLoS ONE"},{"issue":"6","key":"388_CR216","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.jid.2016.01.027","volume":"136","author":"OM Gannon","year":"2016","unstructured":"Gannon OM, Merida de Long L, Saunders NA. DUX4 is derepressed in Late-Differentiating keratinocytes in conjunction with loss of H3K9me3 epigenetic repression. J Invest Dermatol. 2016;136(6):1299\u2013302.","journal-title":"J Invest Dermatol"},{"key":"388_CR217","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/biolre\/ioaa179","volume":"104","author":"D Bosnakovski","year":"2021","unstructured":"Bosnakovski D, Gearhart MD, Choi SH, Kyba M. Dux facilitates post-implantation development, but is not essential for zygotic genome activation. Biol Reprod. 2021;104:83\u201393.","journal-title":"Biol Reprod"},{"issue":"6","key":"388_CR218","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41588-019-0418-7","volume":"51","author":"Z Chen","year":"2019","unstructured":"Chen Z, Zhang Y. Loss of DUX causes minor defects in zygotic genome activation and is compatible with mouse development. Nat Genet. 2019;51(6):947\u201351.","journal-title":"Nat Genet"},{"key":"388_CR219","doi-asserted-by":"crossref","unstructured":"Guo Y, Kitano T, Inoue K, Murano K, Hirose M, Li TD, Sakashita A, Ishizu H, Ogonuki N, Matoba S et al. Obox4 promotes zygotic genome activation upon loss of Dux. eLife 2024, 13:e95856.","DOI":"10.7554\/eLife.95856"},{"issue":"4","key":"388_CR220","doi-asserted-by":"publisher","first-page":"C655","DOI":"10.1152\/ajpcell.00116.2019","volume":"317","author":"ML Ruebel","year":"2019","unstructured":"Ruebel ML, Vincent KA, Schall PZ, Wang K, Latham KE. SMCHD1 terminates the first embryonic genome activation event in mouse two-cell embryos and contributes to a transcriptionally repressive state. Am J Physiol Cell Physiol. 2019;317(4):C655\u201364.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"388_CR221","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cell.2018.05.043","volume":"174","author":"M Percharde","year":"2018","unstructured":"Percharde M, Lin CJ, Yin Y, Guan J, Peixoto GA, Bulut-Karslioglu A, Biechele S, Huang B, Shen X, Ramalho-Santos M. A LINE1-Nucleolin partnership regulates early development and ESC identity. Cell. 2018;174(2):391\u2013405. e19.","journal-title":"Cell"},{"issue":"4","key":"388_CR222","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41588-024-01692-z","volume":"56","author":"M Vega-Sendino","year":"2024","unstructured":"Vega-Sendino M, Luttmann FF, Olbrich T, Chen Y, Kuenne C, Stein P, Tillo D, Carey GI, Zhong J, Savy V, et al. The homeobox transcription factor DUXBL controls exit from totipotency. Nat Genet. 2024;56(4):697\u2013709.","journal-title":"Nat Genet"},{"issue":"10","key":"388_CR223","doi-asserted-by":"publisher","first-page":"107823","DOI":"10.1016\/j.isci.2023.107823","volume":"26","author":"D Bosnakovski","year":"2023","unstructured":"Bosnakovski D, Toso EA, Ener ET, Gearhart MD, Yin L, Luttmann FF, Magli A, Shi K, Kim J, Aihara H, et al. Antagonism among DUX family members evolved from an ancestral toxic single homeodomain protein. iScience. 2023;26(10):107823.","journal-title":"iScience"},{"issue":"5","key":"388_CR224","doi-asserted-by":"publisher","first-page":"e1008754","DOI":"10.1371\/journal.pgen.1008754","volume":"16","author":"S Jiang","year":"2020","unstructured":"Jiang S, Williams K, Kong X, Zeng W, Nguyen NV, Ma X, Tawil R, Yokomori K, Mortazavi A. Single-nucleus RNA-seq identifies divergent populations of FSHD2 myotube nuclei. PLoS Genet. 2020;16(5):e1008754.","journal-title":"PLoS Genet"},{"issue":"5","key":"388_CR225","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/ng.3535","volume":"48","author":"T Yasuda","year":"2016","unstructured":"Yasuda T, Tsuzuki S, Kawazu M, Hayakawa F, Kojima S, Ueno T, Imoto N, Kohsaka S, Kunita A, Doi K, et al. Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults. Nat Genet. 2016;48(5):569\u201374.","journal-title":"Nat Genet"},{"key":"388_CR226","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ebiom.2016.04.038","volume":"8","author":"YF Liu","year":"2016","unstructured":"Liu YF, Wang BY, Zhang WN, Huang JY, Li BS, Zhang M, Jiang L, Li JF, Wang MJ, Dai YJ, et al. Genomic profiling of adult and pediatric B-cell acute lymphoblastic leukemia. EBioMedicine. 2016;8:173\u201383.","journal-title":"EBioMedicine"},{"key":"388_CR227","doi-asserted-by":"publisher","first-page":"11790","DOI":"10.1038\/ncomms11790","volume":"7","author":"H Lilljebjorn","year":"2016","unstructured":"Lilljebjorn H, Henningsson R, Hyrenius-Wittsten A, Olsson L, Orsmark-Pietras C, von Palffy S, Askmyr M, Rissler M, Schrappe M, Cario G, et al. Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia. Nat Commun. 2016;7:11790.","journal-title":"Nat Commun"},{"issue":"12","key":"388_CR228","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/ng.3691","volume":"48","author":"J Zhang","year":"2016","unstructured":"Zhang J, McCastlain K, Yoshihara H, Xu B, Chang Y, Churchman ML, Wu G, Li Y, Wei L, Iacobucci I, et al. Deregulation of DUX4 and ERG in acute lymphoblastic leukemia. Nat Genet. 2016;48(12):1481\u20139.","journal-title":"Nat Genet"},{"issue":"3","key":"388_CR229","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.nmd.2016.12.007","volume":"27","author":"TI Jones","year":"2017","unstructured":"Jones TI, Himeda CL, Perez DP, Jones PL. Large family cohorts of lymphoblastoid cells provide a new cellular model for investigating facioscapulohumeral muscular dystrophy. Neuromuscul Disord. 2017;27(3):221\u201338.","journal-title":"Neuromuscul Disord"},{"key":"388_CR230","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1093\/hmg\/ddaa053","volume":"29","author":"CRS Banerji","year":"2020","unstructured":"Banerji CRS, Panamarova M, Zammit PS. DUX4-expressing immortalised FSHD lymphoblastoid cells express genes elevated in FSHD muscle biopsies, correlating with the early stages of inflammation. Hum Mol Genet. 2020;29:2285\u201399.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"388_CR231","doi-asserted-by":"publisher","first-page":"17547","DOI":"10.1038\/s41598-020-74687-5","volume":"10","author":"M Signorelli","year":"2020","unstructured":"Signorelli M, Mason AG, Mul K, Evangelista T, Mei H, Voermans N, Tapscott SJ, Tsonaka R, van Engelen BGM, van der Maarel SM, et al. Evaluation of blood gene expression levels in facioscapulohumeral muscular dystrophy patients. Sci Rep. 2020;10(1):17547.","journal-title":"Sci Rep"},{"issue":"9","key":"388_CR232","doi-asserted-by":"publisher","first-page":"113114","DOI":"10.1016\/j.celrep.2023.113114","volume":"42","author":"AA Smith","year":"2023","unstructured":"Smith AA, Nip Y, Bennett SR, Hamm DC, Lemmers R, van der Vliet PJ, Setty M, van der Maarel SM, Tapscott SJ. DUX4 expression in cancer induces a metastable early embryonic totipotent program. Cell Rep. 2023;42(9):113114.","journal-title":"Cell Rep"},{"issue":"5","key":"388_CR233","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.devcel.2019.06.011","volume":"50","author":"GL Chew","year":"2019","unstructured":"Chew GL, Campbell AE, De Neef E, Sutliff NA, Shadle SC, Tapscott SJ, Bradley RK. DUX4 suppresses MHC class I to promote cancer immune evasion and resistance to checkpoint blockade. Dev Cell. 2019;50(5):658\u201371.e7.","journal-title":"Dev Cell"},{"key":"388_CR234","doi-asserted-by":"crossref","unstructured":"Spens AE, Sutliff NA, Bennett SR, Campbell AE, Tapscott SJ. Human DUX4 and mouse dux interact with STAT1 and broadly inhibit interferon-stimulated gene induction. eLife 2023, 12:e82057.","DOI":"10.7554\/eLife.82057"},{"key":"388_CR235","doi-asserted-by":"crossref","unstructured":"Pineda JMB, Bradley RK. DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers. eLife 2024, 12:RP89017.","DOI":"10.7554\/eLife.89017"},{"key":"388_CR236","doi-asserted-by":"crossref","unstructured":"Friedel CC, Whisnant AW, Djakovic L, Rutkowski AJ, Friedl MS, Kluge M, Williamson JC, Sai S, Vidal RO, Sauer S et al. Dissecting herpes simplex virus 1-Induced host shutoff at the RNA level. J Virol 2021, 95(3):e01399-20.","DOI":"10.1128\/JVI.01399-20"},{"key":"388_CR237","doi-asserted-by":"publisher","first-page":"1286617","DOI":"10.3389\/fimmu.2023.1286617","volume":"14","author":"E Neugebauer","year":"2023","unstructured":"Neugebauer E, Bastidas-Quintero AM, Weidl D, Full F. Pioneer factors in viral infection. Front Immunol. 2023;14:1286617.","journal-title":"Front Immunol"},{"issue":"2","key":"388_CR238","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41582-022-00762-2","volume":"19","author":"MS Tihaya","year":"2023","unstructured":"Tihaya MS, Mul K, Balog J, de Greef JC, Tapscott SJ, Tawil R, Statland JM, van der Maarel SM. Facioscapulohumeral muscular dystrophy: the road to targeted therapies. Nat Rev Neurol. 2023;19(2):91\u2013108.","journal-title":"Nat Rev Neurol"},{"key":"388_CR239","doi-asserted-by":"crossref","unstructured":"Teveroni E, Pellegrino M, Sacconi S, Calandra P, Cascino I, Farioli-Vecchioli S, et al. Estrogens enhance myoblast differentiation in facioscapulohumeral muscular dystrophy by antagonizing DUX4 activity. J Clin Invest. 2017;127(4):1531\u201345.","DOI":"10.1172\/JCI89401"},{"key":"388_CR240","doi-asserted-by":"publisher","first-page":"926421","DOI":"10.3389\/fcell.2022.926421","volume":"10","author":"A Joliot","year":"2022","unstructured":"Joliot A, Prochiantz A. Unconventional secretion, gate to Homeoprotein intercellular transfer. Front Cell Dev Biology. 2022;10:926421.","journal-title":"Front Cell Dev Biology"}],"container-title":["Skeletal Muscle"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-025-00388-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13395-025-00388-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-025-00388-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:59:54Z","timestamp":1757426394000},"score":1,"resource":{"primary":{"URL":"https:\/\/skeletalmusclejournal.biomedcentral.com\/articles\/10.1186\/s13395-025-00388-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":240,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["388"],"URL":"https:\/\/doi.org\/10.1186\/s13395-025-00388-0","relation":{},"ISSN":["2044-5040"],"issn-type":[{"value":"2044-5040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Alexandra Belayew is co-inventor on a patent \u201cAgents useful in treating FSHD\u201d owned by the University of Mons and licensed to Dyne Therapeutics. The other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}